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Research Needs for the Risk Assessment
of Health and Environmental Effects
of Endocrine Disruptors: A Report
of the U.S. EPA-sponsored Workshop
Robert J. Kavlock,1 George R Daston,2 Chris DeRosa,3 Penny
Fenner-Crisp,4 L. Earl Gray,1 Steve Kaattari,5 George Lucier,6
Michael Luster,6 Michael J. Mac,7 Carol Maczka,8 Ron Miller,9
Jack Moore,10 Rosalind Rolland,"1 Geoffrey Scott,12 Daniel
M. Sheehan,13 Thomas Sinks,14 and Hugh A. Tilson1
The hypothesis has been put forward that humans and wildlife species have suffered adverse
health effects after exposure to endocrine-disrupting chemicals. Reported adverse effects include
declines in populations, increases in cancers, and reduced reproductive function. The U.S.
Environmental Protection Agency sponsored a workshop in April 1995 to bring together interested parties in an effort to identify research gaps related to this hypothesis and to establish priorities for future research activities. Approximately 90 invited participants were organized into work
groups developed around the principal reported health effects-carcinogenesis, reproductive toxicity, neurotoxicity, and immunotoxicity-as well as along the risk assessment paradigm-hazard
identification, dose-response assessment, exposure assessment, and risk characterization.
Attention focused on both ecological and human health effects. In general, the group felt that the
hypothesis warranted a concerted research effort to evaluate its validity and that research should
focus primarily on effects on development of reproductive capability, on improved exposure
assessment, and on the effects of mixtures. This report summarizes the discussions of the work
Environ Health Perspect
groups and details the recommendations for additional research.
1 04(Suppl 4):715-740 (1996)
Key words: endocrine disruptors, hormones, risk assessment, carcinogenesis, reproductive
toxicity, developmental toxicity, immunotoxicity, neurotoxicity, exposure assessment,
research needs

Introduction
Evidence has been accumulating which
indicates that humans and domestic and
wildlife species have suffered adverse health
consequences from exposure to environmental chemicals that interact with the
endocrine system (e.g., 1-3). To date,
these health problems have been identified
primarily in domestic or wildlife species

with relatively high exposures to organochlorine compounds, including 1,1,1trichloro-2,2-bis(p-chlorophenyl)ethane
(DDT) and its metabolites, polychlorinated biphenyls (PCBs) and dioxins, or to
naturally occurring plant estrogens. It is
not known if similar effects are occurring
in the general human population, but

again there is evidence of adverse effects in
populations with relatively high exposures.
Several reports (4) of declines in the quality and decreases in the quantity of sperm
production in humans over the last four
decades and reported increases in incidences of certain cancers (breast, prostate,
testicular) that may have an endocrinerelated basis have led to speculation about
environmental etiologies. However, considerable scientific uncertainty remains
regarding the causes of these reported
effects. Nevertheless, it is known that the
normal functions of all organ systems are
regulated by endocrine factors, and small
disturbances in endocrine function, especially during certain stages of the life cycle such
as development, pregnancy, and lactation,
can lead to profound and lasting effects.
The critical issue is whether sufficiently high
levels of endocrine-disrupting chemicals exist
in the ambient environment to exert adverse
health effects on the general population.
Current methodologies for assessing
human and wildlife health effects (e.g., the
generation of data in accordance with testing guidelines developed by the U.S.
Environmental Protection Agency [U.S.
EPA]) are generally targeted at detecting
effects rather than mechanisms, and may
not adequately evaluate effects on the
endocrine system. This is particularly true
for exposures that occur during critical
developmental periods when the endocrine
system plays a key role in regulating essential physiological and morphological
processes. Given the potential scope of the
problem, the possibility of serious adverse
effects on the health of human and wildlife
populations, and the broad occurrence and
persistence of some endocrine-disrupting
agents in the environment, it is important
to focus the available resources for research
on the most critical gaps in our knowledge
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base so that more informed regulatory and
public health decisions can be made in the
future. The broad nature of the problem
necessitates a coordinated effort on both
the national and the international levels.
The National Science and Technology
Council, which advises the president and his
Cabinet on directions for federal research
and development efforts, has established a
milestone for 1995 to 1998 to produce a
national research strategy on endocrine-disrupting chemicals. Therefore, in response to
the growing public health concerns related
to chemicals in the environment that have
the potential to act as endocrine disruptors,
the Office of Research and Development of
the U.S. EPA held a workshop on April
10-13, 1995, in Raleigh, North Carolina,
to begin developing a national research
strategy related to endocrine-disrupting
chemicals. An organizing committee was
formed that consisted of representatives
from various organizations, including the
U.S. EPA, Department of Health and
Human Services, Department of the
Interior, Department of Commerce, and
Department of Agriculture; industrial
groups such as the Chemical Manufacturers
Association and the American Industrial
Health Council; independent organizations
such as the Institute for Evaluating Health
Risks; and public interest groups such
as the World Wildlife Fund and the
Environmental Defense Fund.
The premise of the workshop was as
follows: because environmental endocrine
disruptors have caused a variety of adverse
biological effects in wildlife species, domestic animals, and humans, we need to identify specific research that would assist the
federal government in making informed
decisions. An environmental endocrine
disruptor was broadly defined as "an exogenous agent that interferes with the production, release, transport, metabolism, binding, action or elimination of natural hormones in the body responsible for the
maintenance of homeostasis and the regulation of developmental processes." This
definition reflects a growing awareness that
the issue of endocrine disruptors in the
environment extends considerably beyond
that of exogenous estrogens and includes
antiandrogens and agents that act on other
components of the endocrine system such
as the thyroid and pituitary glands.
Approximately 90 invited participants and
members of the organizing committee
(Table 1) were asked to discuss research
needs related to the principal adverse
health effects reported for endocrine
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disruptors (carcinogenesis, reproductive
[including developmental] toxicity,
immunotoxicity, and neurotoxicity) as well
as research to improve specific components
of the risk assessment paradigm (hazard
identification, dose-response assessment,
exposure assessment, and risk characterization). Attention focused on both ecological
and human health effects. A series of questions was posed to each group to help
guide the discussions. More than 200
observers from academia, industry, governmental organizations, public interest
groups, and the press also attended the
workshop. This report summarizes the
major findings of each discussion group.
Dr. Lynn Goldman, Assistant Administrator, Office of Prevention, Pesticides and
Toxic Substances (OPPTS), U.S. EPA,
opened the workshop. She reviewed the
impact of the National Performance
Review on environmental protection, the
process of updating the OPPTS testing
guidelines, and some regulatory activities
related to endocrine disruptors (e.g., the
special review of triazines, an evaluation
of endosulfan, and the status of the
alkylphenol ethoxylate consent order). Her
presentation emphasized the need to
address the major scientific and policy
questions as the foundation for mitigating
the potential impact of endocrine disruptors. Dr. Howard Bern (University of
California at Berkeley) gave the keynote
address. This historical perspective was
based largely on the human diethylstilbestrol (DES) syndrome and on the neonatal
mouse model used in its experimental
analysis. He emphasized long-term permanent effects in the adult as a result of exposure to agents during development, which
can occur without apparent birth defects in
the neonate. Dr. Bern also emphasized the
concept of critical periods for epigenetic
effects on different targets and indicated
the wide range of organs and physiological
systems that may be affected-reproductive,
endocrine, immune, neural, behavioral,
metabolic, skeletal, etc. The particular sensitivity of systems to endocrine-disrupting
agents during development implies that
embryonic, fetal, and neonatal tissues may
"see" estrogens, estrogen-mimics, and other
endocrine disruptors in a different way
(perhaps even by different mechanisms)
than adult tissues. As a final prelude to the
discussions, representatives from Germany
(Dr. Andreas Gies, Umwelt Bundes Amt),
the United Kingdom (Dr. Linda Smith,
Department of the Environment), and
Denmark (Dr. Jorma Toppari, University

of Turku, Turku, Finland, on behalf of the
Danish Ministry of Environment and
Energy and the Danish Environmental
Protection Agency) presented summaries of
research needs identified by their respective
governments in recent workshops (4-6).

General Comments
from the Work Groups
Each work group consisted of individuals
with various backgrounds including field
ecology, epidemiology, basic sciences, animal and human toxicology, exposure
assessment, and risk assessment. This mix
of experts was perceived as a great advantage in enhancing the groups' ability to
look at the overall problem, stimulating
establishment of common priorities, and
identifying new solutions to existing
methodologic issues. An interdisciplinary
approach should be maintained in any follow-up action to this workshop. Consistent
with the interdisciplinary approach, it is
important that methods and results found
in one research arena be applied to other
research arenas. Basic research (e.g., mechanistic discoveries in cancer etiology)
should be applied to observational research
(e.g., use of DNA polymorphisms in epidemiological or field ecology studies) and
vice versa (e.g., identification of the mechanisms by which DES increases clear-cell
carcinoma of the vagina in women). Sound
scientific information must be the basis of
good decision making. We should be careful not to overinterpret study results when
the basic scientific techniques have not
been standardized or validated. The use of
biologic measurements requires an understanding of good laboratory practices
(QA/QC), reproducibility, accuracy, statistical power, and replicability. In addition,
interpretation that some measurements are
predictive of adverse biological effects
requires validation studies. Finally, the
underlying issue of dose response must
always be considered when results observed
over a limited dose range are evaluated .
Many of the gaps in our understanding
of dose-response relationships for endocrine
disruptors are the same as those that have
led to much uncertainty and associated controversy arising from using default assumptions made by regulatory agencies in the risk
assessment process. The validity of assumptions used in risk assessments is frequently
challenged when high-dose data in experimental systems are used to estimate effects
at much lower doses in humans. Our growing analytical ability to detect chemicals at
continually lower concentrations, coupled
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Table 1. Work group participants and assignments.
Groupc
Groupc
Affiliationb
Affiliationb
Participanta
ICF Kaiser
Garet Lahivs
C,DR
University of Maryland-Baltimore
1,DR
R,HD
Coral A. Lamartiniere
U.S. EPA
University of Alabama-Birmingham
C,EX
John F. Leatherland
Oregon State University
University of Guelph
1,DR
N,EX
Boston's Children's Hospital
Jonathan J. Li
University of Kansas Medical Center
N,DR
C,EX
George Luciera
NIEHS
University of California-Berkeley
R,HD
C,DRt
Mike Luster
NIEHS
It,DR
U.S. EPA
C,EX
Michael J. Maca
National Biological Service
R,EXt
NCI
C,HD
N,HD
Neil J. MacLusky
The Toronto Hospital
Rutgers University
N,RC
Carol Maczka
National Research Council
University of Colorado
l,EX
R,HDt
N,HD
Peter Mathiessen
MAFF, United Kingdom
Mississipi State University
R,EX
R,RC
Lynne F. McGrath
Hoechst-Celanese
NIEHS
1,DR
R,RC
John McLachlan
Tulane University
Exxon Biomedical Sciences
C,RC
Sue McMastera
U.S. EPA
World Wildlife Fund
l,EX
N,RC
Mark S. Meyers
Northwest Fisheries Science Center
Chemical Industry Institute of Toxicology C,DR
C,RC
Diane Miller
U.S. EPA
Dupont-Haskell Laboratory
N,RC
C,HD
Ron R. Millera
N,HD
DOW Chemical Co.
U.S. EPA
Ct,R
IEHR
John A. Moorea
U.S. EPA
1,RCt
C,HD
Larry L. Needham
CDC
C,EX
University of Texas at Austin
N,RC
R,RC
Reynaldo Patino
National Biological Service
U.S. EPA
R,EX
Richard E. Peterson
R,RC
The Procter and Gamble Co.
Rt,DR
University of Wisonsin-Madison
Warren P. Porter
U.S. EPA
University of Wisconsin-Madison
R,EX
N,RC
NIEHS
ATSDR
Christopher J. Portier
C,EXt
1,DR
Walter Rogan
NIEHS
U.S. EPA
C,RCt
N,RC
R,RC
Rosalind M. Rollanda
World Wildlife Fund
Environmental Health Canada
Rf,HD
Louise M. Ryan
Harvard University
Universite du Quebec a Montreal
O,DR
R,DR
National Marine Fisheries Service
Nt,R
Geoffrey I. Scotta
CWS, Environment Canada
l,EX
R. Woodrow Setzer
U.S. EPA
University of California-Davis
R,HD
R,DR
RC
Daniel M. Sheehana
Robert Wood Johnson Medical School
NCTR/FDA
R,DRt
Barbara B Sherwin
McGill University
NCTR
N,RC
N,RC
Ellen K. Silbergelda
N,HD
N,EX
U.S.EPA
University of Maryland-Baltimore
Thomas Sinksa
CDC
Chemical Industry Institute of Toxicology C,DR
Ct,EX
U.S. EPA
The Procter and Gamble Co.
Ralph Smialowicz
R,HD
I,HD
U.S. EPA
George Stancel
University of Texas Medical School
R,HDt
R,DR
John J. Stegemen
Woods Hole Oceanographic Institute
University of Florida-Gainesville
R,HD
C,EX
Peter Thomas
Mt. Sinai School of Medicine
University of Texas at Austin
R,EX
R,DR
Donald Tillitt
National Biological Service
Oregon State University
R,EX
C,HD
R,RC
Hugh Tilson
U.S. EPA
University of California-Davis
Nt,HD
Jorma Toppari
Indiana University
University of Turku, Finland
N,DR
R,ID
Kamala Tripathia
USDA
C,EX
University of California-Davis
l,EX
Daniel A. Vallero
1,RC
U.S. EPA
N,EX
DOW Chemical Co.
Frederick S. Vom Saal
Wake Forest University
University of Missouri-Columbia
R,DR
R,DR
Chris Waller
U.S. EPA
Northwest Fisheries Science Center
R,RC
C,HD
Patricia Whitten
U.S. EPA
Emory University
R,DR
C,RC
Elizabeth Wilson
It,RC
ViMS, College of William and Mary
University of North Carolina-CH
R,HD
Judith T. Zelikoff
New York University Medical Center
U.S. EPA
l,EX
R,HD
U.S. EPA
R,RC
aOrganizing committee members (Dick Hill, U.S. EPA, and Jim Reisa, NRC, were unable to attend). bATSDR, Agency for Toxic Substances and Drug Reserch; CDC, Centers for
Disease Control; CWS, Canadian Wildlife Service; FDA, Food and Drug Administration; ICF Kaiser; MAFF, Ministry of Agriculture, Fisheries and Food (United Kingdom); NCI,
National Cancer Institute; NCTR, National Center for Toxicological Research; NIEHS, National Institute of Environmental Health Sciences; U.S. EPA, U.S. Environmental
Protection Agency. CC, carcinogenic effects, R, reproductive effects; N, neurological effects; immunological effects; H D, hazard detection methods; DR, dose-response methods; EX, exposure methods; RC, risk characterization methods; t, chairperson; t rapporteur.

Participanta
Mel Anderson
Gerald Ankleya
Christopher J. Bayne
David Bellinger
Howard A. Bern
Linda Birnbaum
Aaron Blair
Joanna Burger
Cynthia Carey
Janice E. Chambers
Robert E. Chapin
James R. Clarka
Theodora Colborna
Rory Conolly
Jon Cook
Ralph Cooper
John Couch
David Crews
Sally Darney
George Dastona
William P. Davis
Chris DeRosaa
Penelope Fenner-Crisp
Warren Foster
Michel Fournier
Glen Fox
D. Michael Fry
Michael A. Gallo
David Gaylor
Ellen Goldey
Tom Goldsworthy
Jay Gooch
L. Earl Gray Jra
Louis J. Guillette
Maureen C. Hatch
Jerry D. Hendricks
Andrew G. Hendrickx
Diane Henshel
David E. Hinton
Mike Holsapple
Claude L. Hughes Jr
Lyndal Johnson
Rod Johnson
Steven L. Kaattari
William Kelce
Carole Kimmel

with the availability of molecular approaches
to detect chemical interactions with biological systems, is creating opportunities and
more tractable approaches to improve lowdose risk estimates. Yet considerable work
remains to be done at the laboratory and
science policy levels before there is widespread acceptance of mechanistic data in
quantitative risk assessments. We need to
improve the use of existing data and to have
better data and predictive models to
strengthen the scientific foundation for esti-

mating dose-response relationships for
endocrine disruptors.
Several considerations are essential to
the examination of the effects of potential
endocrine disruptors. First is the consideration of the different sensitivities at
different ages. In general, the developing
organism is especially sensitive, for example, DES induction of adenocarcinoma of
the vagina in females exposed before the
end of the first trimester of their mother's
pregnancy. The second consideration is a

Environmental Health Perspectives
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direct consequence of the first. Because the
work group recognized the importance of
the developmental stage at exposure, exposure assessment as defined by the National
Research Council (7) was modified (change
noted in italics) to read: "the process of
measuring or estimating the intensity,
frequency, duration, and the timing ofexposure, of humans and wildlife to an agent
currently present in the environment or of
estimating hypothetical exposures that
might arise from releases of new chemi-
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cals." The third consideration is that adverse
effects can arise from either primary or secondary disturbances of endocrine function.
Thus, an indirect-acting endocrine disruptor
affects a systemic target organ first; these
effects in turn may influence the endocrine
system to cause secondary neurotoxicity,
reproductive toxicity, and/or immunotoxicity. Conversely, a direct-acting endocrine
disruptor affects the endocrine system first,
which in turn results in toxicity in other
organ systems. In some aspects it is very
difficult, if not impossible, to separate the
endocrine system from the systemic target
organs, so this distinction should be viewed
in an abstract manner. Obviously, some
chemicals can adversely affect the structure
and/or function of the systemic organs
without any endocrine system involvement. Such chemicals may be considered
direct-acting target organ toxicants. These
relationships are portrayed in Figure 1.
Finally, the development of a research
agenda for endocrine disruptors should be
a national or international effort by many
agencies, not just the U.S. EPA, so that the
limited resources can be used in the most
efficient manner.

Direct acting

endocrine disruptor

_

Indirect acting
endocrine disruptor

Direct acting target
organ toxicant

Figure 1. Abstract representation of the interplay
between the endocrine system and the reproductive,
neurological and immunological systems to illustrate
the complexity of determining the mode of action for
chemicals that cause adverse effects through involvement of the endocrine system.

of Dr. Linda Johnson). A variety of doserelated tumors can be produced in fish
given carcinogens under experimental
laboratory conditions (11). Again, there is
no specific evidence that the development
of these tumors involves a hormonal disruption mechanism. Estradiol and certain
hormone precursors (e.g., dehydroepiandrosterone [DHEA]) act as promotors
after treatment of fishes with carcinogenic
substances such as aflatoxin and N-methylN-nitroso-N'-nitroguanidine (MNNG).
Toxicopathic liver lesions have been associated with contaminant exposure in some
marine fish (10).
Biological Effects Issues
There is a paucity of carcinogenicity
data for other forms of wildlife. One study
Carcinogenic Effects
of beluga whales in the St. Lawrence seaWhat do we know about the carcinogenic way found that approximately 50% of
effects of endocrine-disrupting agents in dead whales examined had neoplasms, of
humans and wildIife? What are the major which about 25% were malignant (12,13).
clas5es ofchemicals thought to be responsiThe hypothesis that endocrine disrupble for these effects? What are the uncer- tion can cause cancer in humans is based
tainties associated uith the reported effents? on the causal association between DES
Numerous field studies of teleost fishes in exposure of pregnant women and clearlocalized highly contaminated areas (i.e., cell adenocarcinoma of the vagina and
"hot spots") have shown high prevalences cervix in their female offspring, hormoneof liver tumors (8-10). The predominant related risk factors for breast and uterine
risk factor that has been associated with cancer, and limited evidence of an assothese liver tumors is exposure to poly- ciation between body burden levels of
aromatic hydrocarbons (PAHs) and to a 1, 1-dichloro-2,2-bis(p-chlorophenyl)ethyllesser degree, PCBs and DDT. Certain ene (DDE) or PCBs and breast cancer
species such as carp and fathead minnows risk. Young women who developed cancer
are more resistant, while trout are more of the vagina were more likely to have had
sensitive. There has been no indication mothers who used DES during pregnancy
that the liver tumors in fish involve an to avoid miscarriage than mothers who did
endocrine modulation mechanism. Other not use the drug (14). This finding has led
than for localized areas of high contamina- to a number of important conclusions.
tion, field studies have shown no increasing First, maternal exposures during gestation
trends for tumors of any type in fish. The can lead to cancer in offspring, and second,
group noted that two tumor registries for it demonstrates that a synthetic estrogen
wildlife species exist in the United States can cause cancer. Some of the male off(the Smithsonian Registry of Tumors in spring of women who took DES display
Lower Animals under the direction of pseudohermaphroditism (15) and genital
Dr. John Harshbarger, and the Armed malformations, including epididymal cysts,
Forces Institute of Pathology's Registry of testicular abnormalities such as small testes
Comparative Pathology under the direction and microphallus, and reduced semen
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quality (16-18). Follow-up surveys of
DES-exposed male offspring, however, have
not shown impairment in fertility or sexual
function (19,20), nor is there evidence of
increased risk of testicular cancer (19).
The most common cancer among
women in the United States is breast cancer. A number of epidemiological studies
have examined the risk factors for breast
cancer. Identified risk factors include several that relate to hormonal activity:
decreased parity, age at first delivery, age at
menarche, age, race, and unopposed estrogen therapy. In addition, breast tumors can
be characterized as to their degree of estrogen-receptor positivity resulting in relevant
prognostic information. The evidence supports a causal relationship between female
breast cancer and hormonal activity.
A number of organochlorine pesticides
or pesticidal metabolites are found in
breast milk and human adipose tissue
(21,22). Several recent cross-sectional studies suggest a possible relationship between
levels of some organohalide residues in
human tissues and breast cancer risk,
although the observations are not entirely
consistent across studies, and no clear relationship has been established (23-30). In
general, these studies suggested that levels
of p,p'-DDE and total PCBs were higher in
fat or serum of women who had breast
cancer than in comparison groups. The
meaning of these findings is unclear, in
part, because p,p'-DDE and the few PCB
congeners that have been tested have little
or no discernible estrogenic activity, while
the short-lived forms of DDT, o,p'-DDT
and o,p'-DDE, have only very weak estrogenic properties. Further, a recent
case-control study with historical data
from serum DDE and PCBs conflicts with
the earlier findings (29). This study
showed no overall effect of serum residue
levels on breast cancer risk, although subcategorical analysis did suggest a possible
increase in risk among black women with
higher levels of serum p,p'-DDE. The
women in these studies, except those in
the study by Henderson et al. (30), were
not exposed to high levels of PCBs or
DDE and the actual differences in levels
measured between cases and controls were
not large. Studies of women occupationally exposed to high levels of PCBs have not
demonstrated an excess risk of breast cancer mortality (31,32). The results of these
studies therefore are equivocal and further
research is needed (including examination
of effects in subsequent generations from
parental exposures).
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Relatively good information exists on
cancer occurrence (incidence) and mortality in the United States over the last several
decades. The best incidence data come
from the Surveillance Epidemiology and
End Results (SEER) cancer registries that
are supported by the National Cancer
Institute (33). Cancer trend data from
1973 to 1991 show that age, race, and sexadjusted total cancer incidence increased
by 31% in males and 14% in females. Incidence rates between 1973 and 1991 for
several hormone-sensitive tissues have
increased (female breast 24%, ovarian 4%,
testicular 41%, prostate 126%) as have several other cancer sites: melanoma (116% in
males, 73% in females); non-Hodgkins
lymphoma (84% in males, 57% in
females); and liver (55% in males, 27% in
females). However, increases in female
breast and male prostate cancers account
for the majority of total cancer increases
experienced by women (52%) and men
(70%) during this time period. The
increases in testicular and ovarian cancer
represent only 1% of the total increase in
cancer incidence. SEER data indicate that
incidences of uterine cancer and male
breast cancer have remained constant or
declined slightly.
Cancer screening is available for breast
and prostate cancer. Recent advances in the
screening process account for some of the
reported increases in cancer incidence.
White et al. (34) reported that although
the increase in breast cancer incidence
for women 25 to 44 years of age can be
explained by screening, screening does not
entirely explain the increase for younger or
older women. Feuer and Wun (35) suggest
that screening may also account for all of
the observed increase in older women. It
has also been suggested that increased
detection of prostatic cancer is due to
increased screening for prostate-specific
antigen (PSA) (36).
Examination of the U.S. EPA database
on pesticide registration for organochlorines showed no correlation of the spectrum of tumor types observed in laboratory
animals with the assertion that the
organochlorines are related to human
breast cancer. Organochlorines frequently
increased the incidence of liver tumors in
rats, but did not increase the incidence of
mammary tumors (P. Fenner-Crisp, personal communication to work group). One
subclass of herbicides, the chloro-S-triazines,
produces an earlier onset of mammary
tumors in Sprague-Dawley rats (37,38),
but there are no epidemiological studies

that suggest a relationship between exposure to triazine herbicide and human breast
cancer. An examination of the National
Toxicology Program (NTP) database
involving approximately 450 animal studies showed increased incidences of mammary tumors in approximately 10% of the
studies. However, based on evaluation of
chemical structures and other available
information, this subset of test substances
is not likely to be estrogenic (39). This
analysis only considered the possibility that
the chemicals were direct estrogen agonists.
It is obvious that other possible mechanisms exist for induction of endocrinemediated tumors.
It was noted that good animal or cellular models do not yet exist for study of
some endocrine-mediated tumors (e.g., testicular), which are reported to be on the
increase in the human population, and that
such models would be useful in testing
cause-and-effect relationships.
What are the research needs related to the
detection of carcinogenic effects of
endocrine disruptors?
Most ecological field studies of cancer
incidence have been devoted to examining
fish in polluted waters. Some efforts have
been made to establish comparison populations by examining nonpolluted waters.
One study collected data that could be
used for background information (11).
There are no ongoing national surveillance
programs for tracking cancer incidence
and mortality in wildlife, but the
Smithsonian Institution does maintain a
tumor registry for fish and wildlife, and
some marine mammal populations are being
tracked for tumors (12,13). When populations of wildlife are evaluated, it is important to establish estimates of the expected
occurrence of cancer. It is also important
to identify special populations at high risk
for cancer on the basis of high exposure or
increased susceptibility. Background data
could then be used for comparisons. Fish
have proven to be the easiest animals to
study. The occurrence of cancers in other
animals should be examined as well.
In environmental settings, certain sentinel species may be useful. Sentinel species
would include wildlife, domestic animals,
or laboratory animals. The goal would be
to identify species that are susceptible to
developing cancer, easily monitored for
cancer, and likely to reflect exposure in a
single ecosystem.
Last, the evaluation of exposures should
be expanded beyond polycyclic aromatic
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hydrocarbons and look at additional types
of endocrine disruptors.
The study of the relationship between
endocrine disruption and female breast
cancer in humans is an obvious priority,
not only because of the high incidence of
this disease, but also because no primary
prevention is available. Hopefully, the relationship between organochlorine exposure
and breast cancer risk will be resolved
soon, given the large number of ongoing
epidemiological studies. Hence, focus
should be placed on additional issues such
as research on other possible environmental
agents, including persistent and nonpersistent (e.g., nonorganochlorine pesticides
and phthalates) environmental chemicals
that may affect the endocrine system.
We should evaluate the relationship
between exposure to endocrine disruptors
and other cancer sites, particularly prostate,
testicular, ovarian, endometrial, and thyroid. It is also important to evaluate cancers of the liver, brain, and lung, as these
cancers are frequently associated with exposure to environmental hazards, although
there is no evidence that exposure to EDCs
is among the known primary risk factors
for these tumors.
Epidemiological data on exposed
human populations have proven useful for
identification of human carcinogens.
Occupational cohorts and cohorts of persons with exceptionally high environmental
exposures [e.g., 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD) in Seveso, Italy (40);
polychlorinated biphenyls (PBBs) in
Michigan (41); and PCBs and polychlorinated dibenzofurans (PCDFs) in Japan (42)
and Taiwan (43)] may be important for
establishing a dose-response relationship.
The highest priority is to identify, register,
and follow populations with documented
and quantitatively verified exposures.
There was discussion regarding the
need to include in utero exposures in standard lifetime cancer bioassays to ensure
protection of the developing offspring. The
available evidence (44-47) does not clearly
demonstrate a significant increase in sensitivity or induction of tumors compared to
postnatal-only exposures. However, others
have suggested that these retrospective
comparisons are not adequate to determine
the need for such exposures with EDCs,
since that mechanism of action is underrepresented in the historical database.
Domestic animals and pets may be
useful to identify carcinogenic hazards.
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What are the highestpriority research needs

for carcinogenic effects?
The following high priority research needs
were identified:
a) A systematic comparison of endogenous versus exogenous substances in terms
of biologic activity, metabolism, structure-activity relationships, etc., with an
initial focus on estrogenicity and rapid
expansion to other steroid hormones. The
exogenous estrogenic substances should
include comparisons of phytoestrogens
as well as other types of xenoestrogens in
relation to endogenous estradiol.
b) Basic research to systematically and
thoroughly evaluate species-, cellular-, and
age-dependent responses, including consideration of mixtures of agonists, partial agonists, and antagonists, at environmentally
relevant ratios and doses.
c) Careful evaluation of toxicity and
mechanistic end points across species, including the determination of dose-response
relationships in relation to human risk.
d) Surveillance data on the occurrence
of tumors in wildlife species.
e) Identification and follow-up health
studies of heavily exposed wildlife and
human populations.
f) Validation and application of biomarkers that might be useful in identifying
exposures as well as adverse outcomes
based upon mechanistic considerations.
Other additional research recommendations included thorough consideration of
the importance of critical timing (i.e., windows) of exposure before and after birth for
carcinogenicity end points; determination
of the role of metabolism (e.g., estradiol) in
relation to certain toxicities such as breast
cancer; identification of susceptibility factors such as polymorphisms that might
result in a predisposition to certain end
points, and assessment of structure-activity
relationships for hormonal activity.

Reproductive Effects
What do we know about the reproductive
and developmental effects of endocrinedisrupting agents in humans and wildlife?
What are the major classes of chemicals
thought responsible for these effects? What
are the uncertainties associated with the
reported effects?
Field and laboratory studies of wildlife
populations and individuals have revealed
effects in offspring that appear to be the
result of endocrine disruption. Examples
include reproductive problems in wood
ducks from Bayou Meto, Arkansas (48);
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wasting and embryonic deformities in multiple targets for these chemicals, and
Great Lakes fish-eating birds (49-56); effects are organ- and life stage-specific.
feminization and demasculinization of Still other reports contain evidence of horgulls (57-60); developmental effects in monal activity due to environmental chemGreat Lakes snapping turtles (61); embry- icals without a direct link to reproductive
onic mortality and developmental dysfunc- effects (90,91).
Translating subtle functional deficits
tion in lake trout and other salminiods in
the Great Lakes (62-64); abnormalities of within individuals into population-level
sexual development in Lake Apopka alliga- effects is the real challenge and will require
tors (65,66); reproductive failure in mink better field observations and laboratory
from the Great Lakes area (67); and repro- studies to more precisely simulate field
ductive impairment in the Florida Panther exposures. The generalizations that can
(68). In each case, detectable concentra- be made are grouped into the following
tions of chemicals with known endocrine- categories:
a) Sensitive stages: Developmental
disrupting effects have been reported in the
animals or in their environment, but an stages are often the most sensitive to expoetiological link has been established for sure. (Development in this instance is
only a few of these observations. In ecolog- defined as broadly as possible to include
ical studies, these effects were not recog- embryonic, fetal, larval, and juvenile
nized until the populations began to stages.) There are specific critical periods of
decline. However, the observation that a sensitivity to endocrine disruption. These
population is stable is not an assurance that may be quite short and there may be more
endocrine-disrupting chemicals are not than one. Critical periods vary for differaffecting reproduction, development, ent organs and species. The unique
and/or growth of individuals.
changes in physiology during development
In humans, there is evidence of adverse may increase sensitivity to endocrine-disreproductive outcomes in the DES sons rupting agents. Also, sensitivity may be
and daughters (see "Carcinogenic Effects" ) sexually dimorphic or distinct in expresand in male offspring from the Yu-Cheng sion if not sensitivity.
Effects on development can be reverspoisoning incident (69). In adults, reproductive dysfunction has been observed in ible because of effects on maturation or
males exposed to kepone (70), and the irreversible because of effects on differentiaduration of lactation has been reported to tion. Often, irreversible effects on differendecrease as the concentration of DDE in tiation have a long latency for expression.
the milk increases (71,72). Egeland et al.
Adult males and females are also affect(73) reported decreased serum testosterone ed by endocrine disruptors, and there may
and increased luteinizing hormone (LH) be physiologic states in the adult (e.g., early
levels in workers exposed to dioxin. There pregnancy) that enhance susceptibility.
also have been reports of declining sperm Much of our knowledge of the action of
quality in males over the last several decades endocrine disruptors in adult humans is
(74,75), but the etiology is far from certain. derived from the use of various steroids as
The most convincing evidence for a gener- pharmacologic agents.
al decline in male reproductive health
b) Types of effects: Endocrine disrupin humans is the increase in testicular can- tor effects vary by species and life stage at
cers noted over the recent past in several which exposure occurs. Endocrine disrupWestern countries (5). Again, the contri- tion can result in morphologic abnormalibution of environmental contaminants to ties of the gonads, reproductive tract, brain,
and other organs; functional and behavioral
this increased rate is unknown.
Further information on reproductive abnormalities; and certain malignancies
effects of endocrine-disrupting chemicals (particularly of the reproductive system or
can be found in Colborn and Clement (1), related structures [e.g., breast]). Functional
Adams (2), Medical Research Council (4), abnormalities include decreased semen
Danish Environmental Protection Agency quality, reduced numbers of sperm, infertil(5), Umweltbudesamt (6), McArthur et al. ity, disrupted estrous or menstrual cycling,
(76), Hoffman (77), Kihlstrom et al. (78), and premature menopause; behavioral
Colborn et al. (79), Jansen et al. (80), abnormalities include altered sexual behavJobling and Sumpter (81), Kelce et al. ior and decreased libido. Functional and
(82), Patnode and Curtis (83), Bergeron et behavioral abnormalities may occur after
al. (84), Guillette (85), Baldwin et al. developmental or adult exposure, although
(86), Dodson and Hanazato (87), Rolland the expression is likely to be different for
et al. (88), and Kelce et al. (89). There are the various life stages.
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Circulating hormone concentrations
may be altered by effects on hormone
metabolism or steroidogenesis. There may
also be effects on cellular function in the
endocrine system or in systems that
respond to the endocrine system mediated
by toxicant interactions on different
receptor classes.
At the more fundamental levels of biological organization, i.e., at the biochemical
and cellular level, there tends to be a great
deal of similarity among vertebrate classes
due to the extreme phylogenetic conservation of hormones and hormone receptor
binding characteristics. However, at higher
levels of biological organization there may
be divergence, as hormone systems may
have different developmental functions in
different phylogenetic groups. As an example, in the absence of androgens, the reproductive tract of mammals develops into a
female phenotype, whereas birds require
estrogens to initiate the female phenotype,
and reptiles use both androgens and
estrogens for sexual differentiation.
c) Agents that act by endocrine disruption: A number of chemicals have produced abnormal development and/or
reproductive function via an endocrine
pathway in some species. It is not the purpose of this report to construct an exhaustive list of these. Instead this list will
include a few illustrative examples and
indicate the classes of chemicals that
appear to be of special concern. However,
not all chemicals of a given class have
similar endocrine-disrupting potential;
also, it is likely that chemicals in other
classes not mentioned may have endocrine
toxicity potential.
Examples of agents that have been
shown to alter reproductive development in
various species via an endocrine mechanism
include:
* Hormones and drugs, including DES,
progestogens, androgens, ecdysteroids
and farnesyl hormones
* Metabolic inhibitors, including
5-a-reductase inhibitors
* Pesticides, including DDT and its
metabolites, chlordecone, and vinclozolin
* Phytoestrogens and mycotoxins
* Other chemicals, including dioxins and
some PCBs
These agents do not need to be persistent to have an effect, particularly if the
exposure occurs during a critical developmental period. Importantly, prior exposure
to persistent chemicals can result in exposure during a critical window of sensitivity

even though external exposure had long
been terminated.
Several other chemical or chemical
classes (e.g., alkylphenols, some phthalates,
bisphenol A) have been shown to interfere
with some endocrine-mediated processes
in some systems, but evidence for effects
on reproductive development in vivo is
lacking. Although these examples suggest
direct involvement with steroid receptors,
nonreceptor pathways are also potentially
important targets.
Last, a discussion of hazard is not complete without mentioning that it takes
some level of exposure to have an effect.
That is, there is a dose-response relationship for all chemicals. It is important to
focus on those chemicals for which endocrine disruption is the most sensitive effect.
Agents that have other effects of concern at
lower doses can be studied and regulated
based on those other effects if they are
considered adverse.
d) Modes of action: Modes of action
include agonistic and antagonistic receptor
binding, and effects on hormone synthesis,
storage, release, transport, and clearance.
There are many receptor-mediated modes
of action, including effects on estrogen,
androgen, progesterone, thyroxine, glucocorticoid, and Ah receptors. Others are
likely to be identified.
In addition to direct effects on receptors,
there are instances of metabolic inhibition
and induction that affect steroidogenesis,
inhibitors of enzymes that modify hormones
(e.g., 5-o-reductase), and effects on plasma
transport proteins and neurotransmitter
levels (e.g., effects on the hypothalamicpituitary axis). Differences between species
may be marked, and this may be one
important source of lack of concordance
across species. Last, it will not be a simple
matter to predict the action of mixtures.
It is noteworthy that some agents interact with more than one receptor type (e.g.,
estrogen, androgen, and progesterone
receptors) and that there may be multiple
mechanisms of action for a single agent,
leading to different dose-response curves
for different outcomes.
e) Species affected: In vertebrates, there
are examples of endocrine disruption from
Mammalia (including humans and laboratory animals) to Pisces. Examples in
invertebrates include gastropod mollusks
(exposed to alkyltin), insects (exposed to
insect growth hormones), and crustaceans.
It is likely that other examples have yet to
be identified. Sensitivity varies by species
and population.

f) Species concordance and divergence:
As noted above, the level of concordance
between species depends on the biological
level of organization being examined. The
greatest homology tends to occur at the
most fundamental levels of organization
and less so at the level of the organism.
Knowledge of mechanisms of action and of

basic comparative endocrinology and
embryology will greatly enhance our ability
to extrapolate among species.
Although we have considerable information on perturbations of reproductive
development as well as on direct effects on
the adult, after exposure to chemicals that
disrupt the normal functioning of the
endocrine system, there remain important
uncertainties. In particular the work group
noted the following:
a) Species-to-species extrapolation:
There is a great deal to learn about basic
aspects of comparative endocrinology and
embryology. Concerning the former, it is
known that birds rely on estrogen for sexual
differentiation, whereas mammals rely on
androgens, and reptiles utilize both estrogens and androgens. While mammals rely
on androgens, it is important to remember
that the androgen serves as a precursor for
estrogen, which is the effective molecule
for sexual differentiation in brain morphology, endocrine secretion, and behavior.
Differences have also been observed in the
specificity of serum-binding proteins. It is
likely that other differences will be found
that will help explain the diverse responses
to endocrine disruptors.
In comparative toxicology, three factors
must be considered. First, there may be
pharmacokinetic differences that affect the
concentration of the active agent at the target site. Second, there may be pharmacodynamic differences in the interactions of
the agent with the molecular target and
subsequent responses. Third, superimposed
on these are differences in the genetic template across species.
b) Availability and reliability of historical
data: Historical trend data are the basis for
identifying adverse health effects by interpreting the extent to which the incidence
of these effects is changing and/or is associated with other time-related trends. These
data are also extremely useful in formulating hypotheses on causation. Therefore, a
robust historical database is important for
further field and epidemiological research.
However, the historical database on human
and animal reproductive end points is not
adequate for our needs. More prospective
and retrospective studies are needed on a
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variety of reproductive parameters. Comprehensive evaluation of reproductive parameters in highly exposed populations (for
example, sons and daughters of mothers
exposed to DES or PCBs) would be useful
to identify the most critical effects for
which historical trend data should be analyzed. Finally, statistical analysis of historical trend data should be rigorous, as patterns of change may suggest potential
underlying causes (e.g., one might suspect
different causes for a single cataclysmic
decrease in sperm count versus a continuous
gradual decline).
c) Effects at low levels of exposure:
Effects at low levels of exposure may be
qualitatively different from effects at
high levels for several reasons, including
multiple mechanisms of action, each of
which takes effect at a different dose level.
Furthermore, an agent may have multiple
effects, each having a qualitatively and
quantitatively different dose-response curve.
d) Latency: It is known that developmental exposure to an endocrine disruptor
can have long latency periods before
expression of an adverse effect, the hallmark being DES-induced vaginal adenocarcinoma. Efforts should be made to
establish prospective registries of highly
exposed populations, such as sons and
daughters of mothers exposed to DES, for
other latent effects, particularly breast,
endometrial, and prostate cancers, as this
group is reaching the age when problems
become more prevalent. Other latent
effects of potential concern include cardiovascular, premature menopause, and
altered reproductive behavior in birds and
other fauna.
e) Relevance of bioaccumulation and
biomagnification: Although it is intuitive
that materials which bioaccumulate and
biomagnify are of special concern to those
species that consume them, the relative
contribution of these processes to toxicity
is dependent on trophic level in the food
web, life stage, physiological conditions
favoring lipid mobilization (e.g., pregnancy, lactation, egg laying), and reproductive
strategy. More work needs to be done
before the contribution of bioaccumulation
and biomagnification to the toxicity of a
particular agent in a particular species can
be fully appreciated.
f) Behavior of mixtures of ligands:
Additivity, synergism, and antagonism of
components of mixtures acting at the
same receptor are complicated by several
factors; for example, the interactions may
be qualitatively different depending on
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the concentration and ratio of each compo- changes that might not otherwise be apparnent of the mixture and whether they are ent until significant losses occur. The
agonists, antagonists, or combinations. It group constructed the following list of
may be possible to construct a set of rules to research needs:
explain the behavior of any mixture, given
a) Establishing cause and effect
satisfactory knowledge of the activities and relationships: Hypotheses generated from
mechanisms of action of each component field observations must be tested in the laband validation of the system. This approach oratory and in controlled field studies. This
limits testing to a large but finite number of will require collection of more complete
chemicals in order to characterize virtually field data on hormone levels, tissue burdens
infinite numbers of mixture components of chemicals, and more measures of marker
and concentration. This should be contrast- expression (e.g., vitellogenin) to guide labed with the impossibility of empirically test- oratory studies. Existing long-term ecologiing every possible mixture.
cal field studies should be identified that
Risk assessment approaches for mix- can be integrated into the endocrine distures also need further refinement. In par- ruptor research agenda to test hypotheses.
ticular, the toxic equivalency factor (TEF) This research must be multi-disciplinary in
approach needs improvement. A common nature, and improved mechanisms for
mechanism of action must be clearly information exchange between field and
demonstrated before initiating the process. laboratory researchers must be established.
When calculating TEFs, the lowest experi- Better statistical models to predict risk
mentally measurable response of the most from observations of exposure and effects
appropriate effect in the most appropriate are also needed.
species should be used consistently.
b) Biomarkers: Better biomarkers are
g) Basic research: Although much is needed that reflect both exposure to and
known about the mechanisms of develop- effects of endocrine disruptors. These
mental effects of endocrine disruptors, biomarkers need to correlate with the most
much more needs to be learned. Two areas sensitive end points associated with
that deserve particular attention are endocrine disruptors. These biomarkers
improved understanding of dose at the must address species differences, sexual
target site and the investigation of addi- dimorphism characteristics, and be life
tional potential modes of action involving stage specific. They must be applied in
paracrine and autocrine signaling pathways. long-term, transgenerational studies to
h) Sensitive populations: Although we identify biomarkers in offspring that can be
are generally aware of the life stages most measured shortly after exposure and that
sensitive to endocrine disruption, there is are predictive of long-term or latent effects.
still some uncertainty about the relative
c) Data collection: More extensive
sensitivity of populations. Marked differ- studies are needed of both highly exposed
ences in the responsiveness of different wildlife and human populations (for
inbred mouse strains to the toxicity of example, sons and daughters of mothers
TCDD suggest that there may be substan- exposed to DES or PCBs) as well as poputial variability of response in other species, lations exposed to a contemporary ambiand for other endocrine disruptors. In ent level of endocrine disruptors.
wildlife populations, there is uncertainty Throughout these studies, researchers
as to whether differences in susceptibility must consider that there may be no unexof subspecies has led to a decrease in posed populations. Research hypotheses
should be evaluated in these populations.
genetic variability.
More information on normal population
What are the research needs related to the variation, as well as regional and seasonal
detection of reproductive and developmen- effects, should be gathered. Both prospectal effects ofendocrine disruptors?
tive and retrospective historical trend
While numerous wildlife and ecosystem information is required for wildlife
pollution studies have assessed reproduc- and human populations in order for
tive end points and a few well-documented researchers to identify adverse reproductive
examples of the effects of EDCs in wildlife health trends (e.g., reduced semen
have been identified, little is known about quality and quantity in humans, reduced
endocrine-disrupting chemical effects in reproductive success in wildlife) and to
most wildlife populations. Structured develop and test hypotheses about their
research on the status and trends of popu- causation when possible.
lations and communities including natural
More data on exposure monitoring
variations is needed to detect population coupled with integrative bioassays of
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effects are needed, which would be facilitated by coordination of different agency
efforts (e.g., National Oceanographic and
Atmospheric Administration [NOAA],
U.S. Fish and Wildlife Service [USFWS],
U.S. Geological Service [USGS], National
Biological Service [NBS]). Traditionally,
exposure data have focused on adults. That
focus must shift to collecting data for the
most sensitive life stages, recognizing that
effects may have prolonged latency periods
before they are manifested.
d) Basic research: Studies on basic
developmental biology need to address the
ontogeny of receptor systems. Classical
approaches to the study of receptor-based
mechanisms may not apply to early developmental periods. Research should be
conducted to identify the end points in
multigenerational studies that are most
sensitive to endocrine disruption. Both
receptor and nonreceptor-mediated mechanisms of endocrine disruption should be
studied, and the normal hormonal environment of the developing organism and
the adult must be better characterized.
Better and cheaper analytical tools need
to be developed, including molecular probes
for gene expression products, and immunoassays for biological tissues. Research efforts
would be greatly facilitated by establishment
of a repository of radiolabeled compounds,
antibodies, and cDNAs available at minimal
cost to researchers. Laboratory studies must
focus on low-dose exposures reflecting realistic environmental levels, environmental
mixtures, and pharmacokinetic parameters, including modeling of nonlinear
dose-response relationships.
e) Mixtures: Because little is known
about the hazards of chemicals in environmentally relevant mixtures, a scientifically
based risk assessment approach is needed to
deal with mixtures. Chemical interactions
can be very complex and need to be characterized at a number of environmentally relevant dose levels. The model of receptor
interaction used in these studies needs to be
carefully examined, as a single receptor can
activate a number of genes, which is a particular concern with environmental mixtures.
A toxic equivalents approach (TEQ) is
potentially useful for assessing the risk posed
by multiple chemicals with a common
mechanism of action. Validation of this
approach should consider multiple variables
such as species differences, sensitivity of the
end point(s) measured, mechanism of
action, nutritional status, co-occurrence of
infection, and doses. The most useful
approach would use the most appropriate

end point in the most appropriate life stage
of the appropriate sensitive species.
f) Screening methods: Given the need
to test many more chemicals for endocrinedisrupting potential, short-term in vivo and
in vitro tests that are rapid, reliable, and
inexpensive must be developed to screen
chemicals for relevant hormonal activity.
Screening methods will only be useful if
they are sensitive to a variety of mechanisms of action by endocrine disruption.
The most sensitive end points need to be
identified. Behavioral and growth parameters are end points to explore further. A
testing approach incorporating both in
vitro and quantifiable in vivo tests that are
validated is needed. Where the mode of
action is known, research on the molecular
basis of the effect of endocrine disruptors
on gene expression is needed to identify
molecular probes reflecting the morphologic and/or functional changes in the reproductive system. Where the particular
mechanism(s) of action of a compound is
unknown, more long-term in vivo assays
are needed. Early life-stage testing in
rodents, fish, and amphibians seems
promising as an in vivo screening method.
Quantitative structure-activity relationship
(QSAR) models need to be developed further to help prioritize compounds for more
extensive testing.
g) Population heterogeneity: The
possibility needs to be studied that
endocrine-disrupting chemicals may be
decreasing the genetic variability of
populations through selection pressure.
Comparisons of liver tumor frequencies,
PAH burdens, age, and length characteristics of brown bullheads collected in the
early 1980s from two tributaries of Lake
Erie strongly support the hypothesis that
the bullheads in the Black River were
subjected to an age-selective mortality associated with a high incidence of PAH-associated liver carcinoma (8). Genetic diversity
estimates for the mitochondrial genome of
this species at these and seven other sites in
the lower Great Lakes in the late 1980s
were always much lower in populations
from the contaminated sites than in nearby
reference sites (92), apparently due to stochastic reductions in population size.
What are the highestpriority research needs
for reproductive and developmental effects?
Developmental and reproductive toxicity is
a problem with important implications for
public health and ecosystem health.
Research is needed to delineate the contribution of endocrine-disrupting chemicals

to the observations of adverse effects on
reproduction and development in humans
and in wildlife populations. Because of the
potential long-term impacts on both individuals and populations, this area deserves
a high research priority.
Among the highest priority needs in
this area are the following:
a) Controlled laboratory tests of
hypotheses generated from field studies.
b) More extensive studies on wildlife
and human populations exposed to high
levels of endocrine-active toxicants (e.g.,
the DES and PCB cohorts) to identify the
adverse health effects most likely to occur
from developmental endocrine disruption.
c) Better definition of normal variability in reproductive parameters and more
comprehensive temporal data (both
prospective and retrospective) so that potential trends can be identified more readily
and reliably, and hypotheses tested regarding their causation.
d) Characterization of the interaction
of mixtures of endocrine-active toxicants,
and the development and validation of risk
assessment methods that adequately
account for these interactions.
e) Development of QSAR and shortterm screening approaches to identify
potential endocrine-active hazards to reproduction and development.

Neurological Effects
What do we know about the neurological

effects of endocrine-disrupting agents in

humans and wildlife? What are the major
classes of chemicals thought to be responsible for these effects? What are the uncertainties associated uwith the reported effects?
The work group determined that neuroendocrine disruption can be induced by multiple mechanisms. Direct effects on endocrine
glands (e.g., the thyroid) may alter the hormonal milieu, which in turn can affect the
nervous system, resulting in neurotoxicity.
Conversely, EDCs may initially act on the
central nervous system (CNS) (e.g., neuroendocrine disruptors), which in turn can
influence the endocrine system. It was
noted that exposure to chemicals can
adversely affect the structure and function of
the nervous system without any endocrine
system involvement. The group considered
several examples of effects produced by disruption of the endocrine system and agreed
that alterations in the following would be
indicative of neuroendocrine disruption:
reproductive behaviors mediated by alterations in the hypothalamic--pituitary axis
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(e.g., courtship and parental behavior in
avian species); alterations in metabolic rate,
which could indirectly affect behavior;
altered sexual differentiation in the brain,
which could affect sexually dimorphic
reproductive and nonreproductive neural
end points; and some types of neuroteratogenic effects. The group concluded that
there were clear examples in the human
and animal literature in which exposure to
endocrine disruptors had occurred and
effects on behavior, learning and memory,
attention, sensory function, and psychomotor development were observed
(60,76,79,93-110). Some of these effects,
however, can also be produced by developmental neurotoxicants having little or no
known endocrine-disrupting properties
and, therefore, cannot be regarded as
specific to the endocrine-disrupting class of
chemicals. It was also pointed out that
exposure to a number of nonchemical factors (e.g., food or oxygen deprivation, infections, and temperature) could also adversely
affect the nervous system resulting in effects
similar to those produced by endocrine disruptors. These nonchemical factors may
also interact in as yet unpredictable ways
with chemical stressors. Therefore, considerable care should be taken to eliminate
nonchemical causes before concluding that
neurotoxicity is causally related to the
effects of a chemical acting on the
endocrine system.
The group concluded that there were
several examples of chemicals or classes of
chemicals that produce neurotoxicity by an
endocrine mechanism. It was agreed that
environmental toxicologists should consider the dose at which neuroendocrine dysfunctions are produced relative to the concentrations existing in the environment
and relative to dose levels at which other
toxic effects occur, the relationship between
exposure and effect, and the role of naturally occurring chemicals with endocrinemimicking properties. With these caveats
in mind, examples of directly or indirectly
acting neuroendocrine disruptors include
some PCBs, dioxins, DDT and related
chlorinated pesticides and their metabolites, some metals (methylmercury, lead,
organotins), insect growth regulators,
dithiocarbamates, synthetic steroids,
tamoxifen, phytoestrogens, and triazine
herbicides. Identification of chemicals as
neuroendocrine disruptors should be based
on mechanistic information at the cellular
or molecular level in the endocrine system
or defined functionally in terms of activity
on responses known to be mediated by or

724

dependent on hormones. All definitions of
neuroendocrine disruptors should be interpreted specifically with respect to gender,
hormonal status, and developmental stage,
since the expression of toxicities of chemicals may change significantly depending on
these variables.
The group identified a number of
uncertainties critical to understanding the
significance of the effects of neuroendocrine
disruptors, including:
a) Chemicals occur as mixtures in the
environment, thereby making it difficult to
assign cause and effect for specific agents. It
is possible that the parent chemical may
not affect the endocrine system but is
metabolized to an active form. The toxicokinetics of and relative tissue distribution
into the nervous system are generally
unknown for most chemicals; little is
known about the metabolic interaction
between chemicals in mixtures.
b) There are ranges of possible specific
and nonspecific effects that could be measured. Research to date has used only a
small number of techniques and methods,
and it is likely that many neuroendocrine
effects may be subtle and not easily detected
with currently available procedures. It is
also a concern that the functions most sensitive to chemically induced alterations in
neuroendocrine function are the most
difficult to measure in the field.
c) It is critical to know when exposure
occurred relative to when the effects are
measured. Observed effects could be dependent on a number of extrinsic factors such
as seasonal variability and intrinsic factors
such as hormonal status. In addition, the
nervous system is known to be differentially
sensitive to chemical perturbation at various
stages of development. A chemical may
have a significant effect on neuroendocrine
function if exposure occurs at a critical
period of development but have little or no
effect at other stages of maturation.
d) Several issues related to extrapolation are critical to understanding neuroendocrine disruptors. For example, it is
difficult to evaluate the significance to
human health of a chemically induced
change in a behavior that does not naturally occur in humans, i.e., there are concerns
about the appropriateness of some animal
models for toxicologic studies. In addition,
there are uncertainties about extrapolating
from species to species and from experiments conducted in the laboratory to those
performed in the field.
e) There are uncertainties about the
shape of the respective dose-response

curves for many neuroendocrine effects. It
is likely that some chemicals may have
multiple effects occurring at different
points on the dose-response curve.
f) The group concluded that basic
information concerning the mechanism of
action of chemicals on the developing nervous system and the neurological role of
hormones during development would
greatly reduce uncertainties about risk of
exposure to neuroendocrine disruptors.
Furthermore, it is also important to understand the consistency of the effects relative
to the hypothesis that chemicals are affecting the nervous system.
What are the research needs related to the
detection ofneurological fects ofendocrine

disruptors?

The group considered a number of research
needs:
a) Opportunistic field studies:
Coordinated epidemiological research to
exploit human and wildlife populations,
which have known exposures to neuroendocrine disruptors, to define the biological
effects most likely to occur:
b) Laboratory/field studies: Systematic
field and laboratory studies that focus on
critical experimental uncertainties, e.g.,
dose-response determinations, effects of
different duration of exposures, time of
exposure during development, and age
of assessment and integration of various
end points.
c) Mixtures: Systematic research to
address the principle of additivity in determining the risk associated with exposure to
mixtures.

d) Toxicokinetics: Studies to determine
the age group-dependent toxicokinetics
and toxicodynamics of environmentally
relevant chemicals, with an emphasis on
providing better exposure assessments to
correlate biological effects with target or
tissue dose.
e) Mechanisms of action: Research at
the cellular and molecular levels to provide
a better understanding of the mechanisms
of action for known neuroendocrine
disruptors.
f) Basic research: Research to better
understand the normal development of the
nervous system and the role that endocrine
systems may play in that development.
g) Sentinel species and biomarkers:
Identification of sentinel species and development of biomarkers of exposure and
effects for neuroendocrine disruptors.
h) Identification of sensitive subpopulations: Research to determine if there are
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populations or individuals that may be
differentially sensitive to neuroendocrine
disruptors.
i) Multigeneration assay development:
Multigenerational research in both invertebrates and vertebrates to assess the possible
transmission of effects across generations
What are the highestpriority research needs
for neurologaleffcts?
The group agreed that research concerning
the effects of chemicals on the neuroendocrine system should have a relatively
high priority. Because the developing nervous system is differentially sensitive to
chemicals, there is great concern that lowlevel exposure to environmentally relevant
mixtures of chemicals could have subtle,
long-lasting effects on nervous system function in a number of animal and human
populations. Neurotoxicologic effects have
been documented in children exposed to a
number of environmentally relevant chemicals, including the PCBs, methylmercury,
and lead (111), although these do not necessarily act primarily via endocrine-mediated mechanisms. Finally, the group noted
that the nervous system interacts with or
controls other potential targets (immune
and reproductive systems) and serves as an
interface between the environment and the
internal milieu. It seems likely that effects
on other target systems and the manner in
which organisms perceive and respond to
the environment may involve the neuroendocrine system to some degree. Thus, studies on the mechanisms of neuroendocrine
disruption should provide crucial information concerning mechanisms of other biological effects.
Among the highest priority research
needs in this area are
a) The initial focus on identifying and
documenting effects of concern to humans
and wildlife that are possibly mediated by
the neuroendocrine system
b) Follow-up studies to determine the
parameters of exposure to specific chemicals and the time of assessment of effects
on the neuroendocrine system
c) Demonstration of biological plausibility between exposure to chemicals and
observed effects in humans and wildlife
d) Studies on the potential mechanism
of action of observed effects
e) Attention to the roles of mixture in
the effects produced by neuroendocrine
disruptors
f) Better understanding of the interaction of the nervous system with other
potential targets of endocrine disruptors.

Immunological Effects
What do we know about the immunological effects of endocrine-disrpting agents in
humans and wildlif? What are the major
claes ofchemicals thought responsible for
these effeets? What are the uncertainties
associaed uith the reported effects?
Published studies have demonstrated
associations between autoimmune syndromes and DES exposure (112). A relationship is well established between physiological estrogen levels and autoimmune diseases in women (113-115). The observations that exposure of humans to DES,
TCDD, PCBs, carbamates, organochlorines, organometals, and certain heavy
metals alters immune phenotypes or function are suggestive of immunosuppression
and potential disease susceptibility
(116-119). Experimental animal studies
support these observations (e.g., 120-126),
although dose-response information is
needed to clarify whether these are directlyor indirect-acting agents. With respect to
fish and wildlife, it was also noted that several of the agents listed above induce
immune suppression or hyperreactivity
similar to that reported in experimental
animals and humans. Embryonic exposure
of trout to aflatoxin has led to alterations
in adult immune capacity (127-129).
With regard to disease susceptibility and
exposure, there have been examples such as
the dolphin epizootic of 1987 to 1988
(130). In this case there was an association
with PCBs and DDT in the blood,
decreased immune function, and increased
incidence of infections among affected
individuals (131). Impairment in immune
function has been reported in bottlenose
dolphins exposed to PCBs and DDT (132)
and in harbor seals fed fish from polluted
waters (133,134). From 1991 to 1993,
specific immune functions and general
hematologic parameters were measured in
herring gull and Caspian tern chicks from
a number of study sites in the Great Lakes
chosen across a wide range of organochlorine contamination (primarily PCBs). As
the hepatic activity of ethoxyresorufin-0deethylase (EROD), an index of exposure,
increased, thymus mass decreased. At highly contaminated sites both gull and tern
chicks showed marked reductions in Tcell-mediated immunity as measured by
the phytohemagglutinin skin test (135).
A variety of immunoassays have been
used to demonstrate effects in experimental laboratory animals, humans, fish, and
wildlife. These include modulation of

antibody responses (both in vivo and in
vitro), the phytohemagglutinin skin test,
mitogenesis, phagocytosis, levels of complement or lack of acute phase reactants,
cytotoxic T-lymphocyte reactivity, and natural killer cell activity (136-142).
Evidence of an increased rate of
autoimmunity associated with prenatal
DES exposure suggests the possibility that
other endocrine-disrupting chemicals
(EDCs) may induce a similar pathologic
state. Studies are needed to determine if
there has been an increase in cases of
immune dysregulation in areas or sites
where EDC exposures have occurred.
Evidence indicates that the incidences of
allergy and asthma (which are forms of
hypersensitivity) are increasing in humans
(143-145). It is not known whether EDC
exposures are responsible for some part of
this development. Alteration of sex-steroid
balance has been shown to lead to increased
or accelerated onset of autoimmune syndromes in mice (114). In rats and mice,
heavy metals such as lead, mercury, and
gold enhance autoimmune syndromes
(146,147). There have also been reports of
exposures of fish to EDCs in the environment that lead to immune enhancement.
Although autoantibodies have been reported
in sharks and trout (148-150), no attempts
have been made to correlate exposure to
EDCs with incidences of autoantibodies. In
trout, embryonic exposure to aflatoxin B1
can lead to immune stimulation or suppression in the adult, depending upon the
immune parameter analyzed (129). Other
data suggest that small changes in physiologic levels of estrogens can affect the
immune system, and studies in gull and
tern chicks in the Great Lakes clearly indicate that the findings are associated with
developmental exposures (135).
Concerning direct-acting EDCs,
although it would appear that these agents
directly affect the immune system, it is
unknown whether there may be disruptive
effects on the endocrine-immune axis.
Since the immune and endocrine systems
are linked via various cytokine signaling
processes (IL-1, ACTH, catecholamines,
prolactin, and endorphins), it is likely that
EDC effects on the immune system
modulate elements of the endocrine or nervous systems or vice versa. Too little is
known about the dose-response curves for
immunotoxicity, neurotoxicity, or endocrine effects to decipher the independent or
interactive effects on these systems. Because
of the high degree of intercommunication
between these systems, there is a need for
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coordinated and cooperative studies among
laboratories in all these disciplines.
Although the most forceful arguments
for the overall consequences of immune dysfunction would be increased disease incidence, this is difficult to assess in humans
or wildlife populations. Furthermore, only
certain subpopulations (the very young or
elderly) may be affected. Disease may only
be manifested as a population decline.
Disease trials can be undertaken, but they
require controlled laboratory experiments
employing populations of wild animals or
fish that can easily be maintained in the
laboratory. In humans, the variability within a population makes it difficult to decipher exogenously triggered effects.
The fact that employment of a variety
of in vitro assays has been successful in correlative exposure studies leads to the question of whether those immune parameters
can be correlated with the increased risk of
disease. A number of immune parameters
operate independently (i.e., lysozyme levels, complement activity, phagocytosis,
induction of cytotoxic T lymphocytes,
plaque-forming cells, etc.). Which combination of these assessments would make for
an optimal predictive suite of assays?
Knowledge of normal baseline values
for wildlife species, and in most cases
humans, is lacking. If these populations are
to be screened for perturbations in immune
function, control populations must be
defined and standardized control values
obtained. Also, the types of exposures must
be well documented (i.e., dose, length of
exposure, timing).
What are the research needs related to the
detection of immunological effects of
endocrine disruptors?
The work group identified the following
research needs related to the assessment of
immunological risk to human and wildlife
populations:
a) Epidemiological analyses: Human
populations with known exposure should
receive greater attention, concentrating on
the possible association of exposure with
autoimmune symptomology, hypersensitivity, and disease incidence. In wildlife
populations, particularly marine mammals,
analysis must be associative and would
require more rapid and inexpensive methods to quantify or identify the presence of
EDCs. This will require additional live
capture research on marine mammals using
noninvasive sampling techniques to establish appropriate baselines of normality.
It is especially important to coordinate
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immunological research activities with
reproductive, neurological, and carcinogenesis research. The ability to quickly mobilize groups to address environmental problems, with a tested suite of immunoassays,
would be advantageous when new environmental exposures are detected.
b) Mechanisms: Studies on mechanisms
of action must be conducted for agents that
cause endocrine disruption after initial interaction with the immune system. Studies are
also needed that determine the dose level at
which immune effects occur secondary to
endocrine disruption. Exclusive immune
dysfunction at low concentrations would
indicate that the primary target of the
specific EDC would be the immune system.
The endocrine effects caused by many disruptors have not been examined for
immune system effects. Studies are also
needed to characterize potential effects on
the endocrine system of direct-acting
immunotoxicants. The general feeling was
that many of the endocrine disruptors identified thus far act directly upon the immune
system; however, the group did not extensively discuss agents that may affect the
immune system via endocrine disruption
(e.g., ammonia).
c) Mixtures: Identification of the
immunotoxic elements within such mixtures would be a primary aim, although
more information would be gained if coordinated studies were conducted between
endocrinology, developmental, and neurobiology laboratories. In addition, inexpensive analytical tools are needed to analyze
contaminant body burdens. Although
there was some amount of uncertainty in
the group as to the value of bioassays to
grossly quantify classes or groups of EDCs,
this avenue might provide an inexpensive
means of assessing exposure. However,
most samples would be comprised by the
presence of mixture and the contributions
of agonists and antagonists to the EDC
would further complicate analysis.
d) Critical periods: Because studies are
lacking on developmental exposure, they
will have to be conducted in the laboratory, in long-term human epidemiological
studies, or with individually marked
wildlife populations. To date, work with
agents that have an initial impact on the
endocrine system has demonstrated that
the most compelling evidence is related to
developmentally acquired dysfunction.
Furthermore, and perhaps more important,
the effects on the developing immune system may be more persistent or longer lasting than those that might occur with adult

exposure. The doses needed to elicit these
developmental dysfunctions are not as large
as those for acute exposures of adults; thus,
a much greater percentage of populations
may be affected in this way. For some
wildlife species, studies on normal developmental immunobiology would have to be
conducted prior to any extensive EDC
testing on model species.
e) Sentinel species: The choice of model
or sentinel species for the assessment of
EDC effects on the immune system
requires a great deal of forethought. These
choices should be well suited to answer
specific questions (both of an immunological and endocrinological nature). It was felt
that a logical first step might be greatly
expedited by agencies such as the U.S. EPA.
Their access to information concerning the
impact of the environment on populations
throughout the United States could provide
valuable information for determining
potentially good model/sentinel species.
These species should also possess the following characteristics: ease of maintenance
in the laboratory; ubiquitous distribution in
the environment-broad range; accessibility of large numbers; easily bred within a
laboratory environment (permits analysis of
genetic basis of susceptibility required for
developmental analysis and eliminates
carry-over environmental effects in doseresponse experiments); substantial database
on physiologic parameters; inexpensive cost
of procurement and maintenance; ecological relevance; short generation time and
representative of a large number of species
or, at least, groups of species
Upon selection of model species, there
should be coordinated optimization and
standardization of the immunological assays
and their analyses. Major gaps in the endocrine and immune databases of selected
species must be addressed immediately.
The entire repertoire of sentinel species
should account for the variety of environmental conditions that may modulate
either the exposure or response to EDCs,
including temperature (if an ectotherm),
trophic level, and other conditions of the
particular niche (i.e., salinity, exposure to
sediment, water column, atmosphere.
f) Ecological monitoring: Studies of
marked wildlife populations are needed
to determine the effects of contaminants
on the demographics and to monitor the
age and accumulation of EDCs within
tissues. Some of the sentinel species used
in these studies need to be relatively
hardy while others may need to be rather
sensitive. For example, trout are often the
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first to disappear from a contaminated site,
thus suggesting the first indication of a
problem. Although this feature in and of
itself may be a good marker attribute for a
sentinel species, it is also advantageous for
the animal to be hardy enough to remain
on the site so sampling can reveal the
nature of the disorders that occur.
What are the highestpriority research needs
for immunologic effects?
The work group agreed that the highest
research priorities should go to areas where
the risk to human and animal life is the
greatest. If the impact is on the immune
system, the risk to life could obviously be
tremendous and would necessitate a commitment to immunotoxicologic research in
this area. However, before such action is
taken, it was felt that the existence of such
problems should be determined by conducting epidemiological analyses of
human, wildlife, and sentinel species, as
described in the previous section. If risk
appears considerable, research should then
be directed toward developmental effects as
well as toward acute effects, and work
should begin as outlined with the most
appropriate sentinel/model species.
Among the highest priority research
needs are
a) Epidemiological studies in both
human and wildlife populations are needed
to establish the incidence of immune-related diseases, including immunosuppression,
hypersensitivity, and autoimmunity associated with exposure to endocrine-disrupting
agents and to determine the impact of
these effects on clinical diseases such as
infections and cancer.
b) Basic research is required to identify
the mechanisms and individual substances
that alter the immune system, and to
determine whether they act directly or
indirectly through alterations of endocrine
system function. Included in this research
should be determination of dose-response
relationships.
c) Methods need to be developed,
particularly for wildlife species, to identify
and validate sensitive assays that detect
immune effects including the selection of
appropriate sentinel species. Included in
this process should be the development
of biomarkers.
d) Studies are needed to determine
whether sensitive populations exist. Based
upon existing evidence, the immunologic
effects of these substances on the very young
(i.e., during the developmental phase) are
of particular concern.

Risk Methodology Issues
levels, behavior, transgenerational effects
on the offspring) often considered
Hazard Identification
fundamental in mammalian testing.
Human health testing guidelines.
Hazard identification includes the collection and evaluation of toxicity data from Various forms of the a) 2-year cancer
bioassay; b) 90-day subchronic toxicity
test systems, epidemiological studies, case
study; c) multigenerational reproduction
reports, and field observations. The number
of species evaluated, the number of studies study; d) developmental toxicity study;
conducted, the quality of the studies, end e) developmental neurotoxicity tests; and
points evaluated, and other factors are f) immunotoxicity tests were discussed.
assessed in the context of dosage, route, tim- Although these tests are generally used to
ing, and duration of exposure. These data evaluate the impact on human health, they
also play a role in assessing effects in mamare used to determine whether the agent in
question poses a hazard, and the context in malian wildlife species.
It was the consensus of the work group
which it poses a hazard (i.e., is it route
specific, species specific, life stage specific, that these tests are intended to detect effects,
etc.). Discussion focused mainly on prospec- not to identify mechanisms. For endocrine
tive hazard detection, whereas from the eco- disruption, the current tests in many cases
logical perspective, retrospective analysis may fail to determine the appropriate no
related to post-environmental release of con- observed adverse effect level (NOAEL) and
taminants is often the more important issue. may fail to detect the reproductive toxicity
This dichotomy was explored further by the of estrogenic pesticides [e.g., methoxychlor
subsequent U.S. EPA-sponsored workshop (152)]. Implementation of the Harmonized
Reproductive and Developmental Toxicity
devoted to ecological issues (151).
Test Guidelines (153) from the U.S. EPA
What are the existingguidelines/testingpro- will improve the ability of these tests
tocols that evaluate endocrine-related to detect the appropriate NOAELs, includeffects?
ing those related to endocrine effects.
Ecological test guidelines. The following However, none of the current or proposed
ecological tests are commonly conducted test guidelines require the measurement of
during the evaluation of industrial chemi- serum hormone levels. In addition, these
cals and pesticides. Tests marked with an tests are poorly designed to evaluate latent
asterisk offer the opportunity to detect effects that result from exposure early in
effects relevant to endocrine disruption. It life. It was stated by the work group that
should be noted that the end points of the Immunotoxicity and Developmental
growth and reproduction measured in Neurotoxicity Test Guidelines were not
these tests are apical, and hence possibly specifically designed to detect the effects of
reflect effects caused by an underlying endocrine disruptors on immune function
endocrine-linked mechanism. However, or CNS development, and, although the
because of this integration, an explicit basic two-year cancer bioassay can and does
endocrine mechanism would not be impli- detect tumors of endocrine organs, transplacated. The tests include a) short- and long- cental carcinogenesis is not evaluated
because the study design does not include
term algal toxicity; b) acute and chronic
reproduction* tests in aquatic and terrestri- exposure during critical stages of developal invertebrates; c) acute, chronic*, early ment (i.e., prenatal, neonatal, infantile, and
(embryo, larval*) and full life-cycle* tests in pubertal stages of life). It was also noted
fish; d) acute, 14-day, and longer-term that current tests generally examine only a
reproduction studies*, and egg-dosing single chemical at a time, which does not
studies of hatchabilty and teratology* in reflect the real world in which exposure is
avian species; and e) acute and chronic to complex mixtures of chemicals.
effects in plants. Ecological testing uses a
small number of surrogate species to repre- What areas within the present guidelines
need refining and improving for the adesent the environment; therefore, the diversity of reproductive and developmental quate evaluation of effects ofendocrine disstrategies contained within aquatic and ruptors?
terrestrial organisms may not be fully In light of the previously mentioned shortaddressed. It was noted that some of these comings of the current testing guidelines,
the work group proposed that research be
tests require development of appropriate
positive and negative controls and standard- conducted to develop and validate apical
ization. Furthermore, they typically do not methods to detect endocrine disruptors.
address sublethal effects (e.g., hormone Once validated, these methods could be
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included in the appropriate test guidelines.
Examples of areas where improvements are
warranted are as follows:
Ecological tests. Because of the lack of an
assessment for transgenerational effects in
ecological tests, a number of additions were
proposed to the current ecological test
guidelines. Research is needed to develop
and validate new testing procedures.
a) Avian reproduction studies should
include an assessment of growth, viability,
fecundity, reproductive morphology, and
behavior in birds exposed in ovo.
b) Some fish species with a short life
cycle may prove to be useful models in
which to examine EDCs in the laboratory.
They can be studied from prefertilization,
through fertilization, hatching, recruitment
into the breeding population, and fecundity during adulthood. Their hormonal systems are well characterized and they are
susceptible to hormonally induced cancers.
Assay methods for hormonal systems of
nonmammalian vertebrates need to be validated and made available to field biologists
on a much larger scale than currently
exists. Additional life-cycle studies for
invertebrates as well as fish are needed to
provide a more holistic hazard assessment
for EDCs.
c) Sexual differentiation studies in invertebrates, fish, reptiles, birds and mammals.
Human health and mammalian tests
(also for other vertebrates, as appropriate).
a) Evaluation of weights, histology, and
hormone production (in vivo with
endocrine challenge tests, or in vitro after in
vivo exposure) of endocrine organs (testis,
ovary, thyroid, adrenal, pituitary, etc.) in
long-term tests [e.g., (154)].
b) Determination of testicular, epididymal, and ejaculated sperm counts.
c) Establishment of landmarks of
puberty and reproductive senescence in
male and female rats and other species.
d) Assessment of sexually dimorphic
behaviors and other CNS functions.
e) Expansion of developmental toxicity
studies to include perinatal exposure and a
postnatal evaluation of reproduction function of the offspring [i.e., the U.S. EPA
Alternative Reproductive Test (ART) protocol (155)]. Studies of the effects of
EDCs on sexual differentiation have been
conducted on members of various classes of
vertebrates including, mammals, birds,
fish, and reptiles. Some invertebrate species
have been examined as well. Such procedures could be used to screen chemicals for
EDC activity. While such tests would not
be short term, they would be shorter and
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less expensive than the current long-term
rodent studies.
f) Evaluation of the need for transplacental carcinogenesis tests for potent
endocrine disruptors, such as DES and
TCDD, as well as for less potent phytoestrogens and synthetic environmental estrogens. Examine the utility of short-term tests
to predict developmental carcinogenicity,
including the methods for estrogenic chemicals (156-157).
g) Determination whether mixtures of
endocrine-disrupting toxicants act in an
additive or nonadditive fashion at low,
environmentally relevant exposure con-

versus those that cause developmental alterations). The group recognized that these
issues warrant further discussion within the
scientific community to reconcile the
disparity in opinions. The work group discussed selected examples of in vivo, in vitro
and QSAR methods that might be
employed to screen for endocrine-disrupting
activity. It was noted that in vivo tests are
often apical while in vitro tests can be more
specific. In vivo tests are more useful if
accompanied by target organ/cell dosimetry
of the biologically active moieties. In vitro
tests also need to determine the actual versus administered concentration of the
centrations.
chemical to account for metabolism, stability, and solubility. Cellular assays must also
Are there, or can there be, developed, short- determine cell viability after toxicant
term in vivo and in vitro techniques to administration. The specificity and limitascreen toxicants for endocrine disruptor tions of each assay must be clearly defined.
activity?
Research is needed to develop and validate
While it was acknowledged that the pro- these assays and to define a testing strategy.
posed U.S. EPA harmonized test guidelines
Examples of in vivo methods applicable
would detect many or most EDCs, these to the detection of endocrine disruption
are long-term, expensive studies, and for include a) rodent models of transplacental
these reasons, short-term tests are required carcinogenesis; b) sexual differentiation
to screen more efficiently the large number studies in mammals, reptiles, fish, and
of environmental agents.
birds (in ovo); c) acute and subacute studSome participants felt that in vitro ies of EDCs on endocrine systems (includmethods could be used for such screening. ing the hypothalamic-pituitary-gonadal
However, because large numbers of in vitro axis, adrenal and other endocrine axes,
tests would be needed due to the plethora uterine weight and biochemical responses
of mechanisms by which EDCs act (i.e., to estrogens, epididymal and sex accessory
altering hormone synthesis, transport, gland function, LH surge and ovulation,
receptors, metabolism), there was also and pregnancy maintenance including in
strong support for in vivo testing. In addi- vitro ovarian and placental steroidogenesis);
tion, it is not clear how in vitro data could d) pubertal alterations induced in male and
or would be used in the risk assessment female rats by EDCs (including landmarks
process. It was noted that when the in vivo of puberty, serum reproductive, adrenal and
concentration of active moieties of an thyroid hormones, reproductive organ
EDC in maternal serum reached the Ki weights, histology, and in vitro hormone
from a receptor binding assay, then all of production from ovarian, testicular, thyroid
the pups would likely be severely mal- and adrenal tissues); and e) in vivo bioassays
formed. Thus, in vitro data could be used in rodent systems (e.g., uterine weight assay
for risk assessment if additional research (157). Clearly, examination is needed of
indicates that delivered doses in the range the rich diversity of species within the aniof the Ki are associated with adverse devel- mal kingdom for useful biomarkers of expoopmental effects. It was also noted that in sure and effect [i.e., vitellogenesis (158)].
vitro potency may not correlate well with Finally, a comprehensive literature search
in vivo toxicity because of mechanistic and and further discussion should be conducted
pharmacokinetic factors. Many experts in to expand the list of existing in vivo screenthe work group stated that in vivo screen- ing methods used by organizations such as
ing systems should be implemented, while the the World Health Organization and the
others felt that a mixture of in vivo, in pharmaceutical industry for the detection of
vitro, and QSAR techniques could be used EDCs.
most efficiently to screen toxicants. It was
Examples of in vitro methodologies
pointed out that screening strategies would applicable to detection of endocrine
vary greatly based on what EDC activity disruption include a) the MCF-7 cell prothe regulatory agencies decide to screen for liferation assay for estrogen and other
(i.e., all mechanisms of action versus a lim- receptors (159); b) competitive receptor
ited subset, like estrogenicity; or all EDCs binding assays for estrogens, androgens,
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and progestins (89,160,161); c) transfected
cell assays for hormonal and antihormonal
activity (162-164); and d) in vitro alterations of whole and minced adrenal, ovarian, testicular, and placental steroidogenesis
or pituitary and hypothalamic hormone
production [e.g., (165)]. Where possible,
attention should be focused on characterizing the difference between developing and
adult tissues in these assays.
In addition to direct biological assays,
the work group noted that 3-D QSAR
models are being developed for ligandreceptor interactions based upon the Ki or
IC50 data derived from androgen, estrogen,
and progesterone competitive binding assays
(166-168). These data are being used as a
training set to develop the QSAR model.
Such models are then tested with chemicals
with known activity, and when validated,
the model can be used to screen libraries of
compounds with unknown activities.
Similar approaches have been successful for
Ah receptor-ligands. Research is needed to
validate and expand the training sets of
these models for the above steroids; similar
efforts need to be initiated for other hormone-receptor interactions. In theory, this
approach could also be expanded to include
toxicant-enzyme interactions. It was noted
that although this technique has incredible
potential utility to screen for EDCs, it can
result in false negatives with chemicals
whose structures lie outside the training set.
Summary of research needs for hazard
identification ofendocrine disruption.
The emphasis for most of the following
research needs is on their application in the
context of identifying the effects of EDCs
in developing organisms. They are
a) Additional validated end points to
supplement current test guidelines and
expand the availability of hormonal assay,
especially for nonmammalian species.
b) Tests and biomarkers to identify
acute and latent effects such as testicular and
prostatic cancer, premature death, shortened
reproductive lifespan, etc.
c) Transplacental toxicology studies for
cancer and noncancer end points.
d) In vivo and in vitro studies of complex mixtures (TEFs for EDCs).
e) Expanded developmental toxicity
studies to include postnatal observations.
f ) Measurement of target organ dosimetry in vivo to determine if adverse effects can
be predicted from in vitro IC50 or Ki values.
g) Expanded training set data for current QSAR models and development of
new models.

h) Correlation of aquatic and wildlife
models with mammalian models.
i) Better coordination of research
among multidisciplinary labs.
j) Improved links between laboratory
and field studies to test hypotheses.
k) Examination of multiple end points
as well as performance of multiple tests on
EDCs.
I) Critical review of additional shortterm in vitro and in vivo tests to screen
EDCs in terms of cost, ease of implementation, specificity, and limitations.
m) Continued discussion on the development of short-term in vitro and in vivo
tests because a complete assessment of
endocrine disruption likely will require
a battery of in vitro and in vivo tests. Such
information will facilitate the use of
mechanistic data in risk assessment.
Dose-Response Assessment
Throughout the discussions on human and
ecological effects of endocrine disruptors,
the workshop participants consistently
agreed that timing of exposure was critical
to the understanding of dose-response
relationships. This is true for the effects of
cancer as well as for the developmental,
reproductive, immunologic, and neurological effects. Numerous examples were discussed, including hormonal influences on
breast cancer where age at exposure is a
known risk factor. Similarly, endocrine disruption of the developing brain can permanently alter behavior, whereas similar exposures to a fully differentiated brain could be
without effect. Ecological and wildlife
effects are also strongly influenced by the
timing of exposure (e.g., during the breeding season). Research is critical on how timing of exposure to endocrine disruptors
influences dose-response relationships.
Before addressing the specific questions
presented to the work group, it is worthwhile to review some of the general recommendations targeted at filling knowledge
gaps that create uncertainty in doseresponse evaluations. These overarching
issues include:
a) Risk assessment issues should be
explicitly considered when studies are
designed for health or ecological effects. Of
particular relevance is the issue of dose
selection. Ideally, the doses used should
span a wide range to identify both toxic and
mechanistic end points, and there should
be sufficient numbers of animals and range
of doses to track the various end points.
b) While there may never be complete
knowledge on the mechanism(s) of action

for any chemical, some knowledge on
key events could be sufficient to justify the
use of mechanistic information in doseresponse evaluations.
c) Mechanistic information is most useful when it is linked to adverse outcomes in
cases in which several discrete events (molecular and biological) are part of the mechanism of action. Within technical and economic limits, dose-response information
should be obtained on as many relevant
events as possible. Identification of mechanistic information on the rate-limiting
steps in the induction of toxicity is a most
useful outcome of this line of research.
d) Population heterogeneity needs to
be characterized to improve risk assessment
decisions. For human health, a number of
factors contribute to a wide range of risks,
including genetic predisposition, age
(embryos, fetuses, and children are not just
small adults), gender, diet, disease conditions, and past exposures. The range of risk
modulators may be even greater for complex ecosystems but little information is
available in this area.
e) Effects of endocrine disrupters on
ecological and human health have both
distinct and common features. Studies to
identify their common features were
strongly recommended by the doseresponse work group.
f) Evaluation of the health and environmental effects of endocrine disruptors
will be most credible when information is
available at several levels such as toxicity,
studies, mechanistic and epidemiological
studies, and field studies. Well-planned
and coordinated multidisciplinary studies
are encouraged.
g) Increased reliance on biology and
mechanisms will create an increased need
to reevaluate potential risks as has occurred
with dioxin.
h) Information exchange systems for
the scientific, regulatory, medical, public
interest, and community sectors need
improvement. The Internet affords an
excellent opportunity to disseminate relevant information to a broad audience.
What are the existing test guidelines and
methodologies used to evaluate endocrinerelated effects? Are there areas within our
present guidelines that need to be refined
and improvedfor the adequate evaluation
of dose-response effects of endocrine

disruptors?
There are no specific guidelines to estimate
dose-response relationships for endocrine
disruptors. Endocrine disruption is inferred
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expected. This conclusion was based on the
many different kinds of hormonal actions
of chemicals categorized as endocrine disruptors. These activities include estrogenic,
antiestrogenic, antiandrogenic, growth factor modulation, cytokine modulation,
modulation of hormone metabolism, and
many others. The conclusion was also
based on the knowledge that there are several steps in hormone action and that different environmental agents may intervene
in different processes.
Moreover, there is considerable cell
specificity in hormone action such that the
same hormone and the same receptor can
produce quantitatively and qualitatively
different responses depending on cell type,
age, and other factors. The diverse mechanisms of hormone action are an active area
of research; it appears that factors such as
receptor number, DNA response elements,
signal amplification, desensitization, interactions with transcription factors, ligand
metabolism, and the presence of cellular
agonists could significantly modify doseresponse relationships for any given
endocrine disruptor (169,170).
What are the research needs in the
evaluation ofdose-response relationships?
The work group felt that research on
mechanisms of hormone action could have
spin-off benefits for improving evaluation
of dose-response relationships. For example, the sensitivity of cells, tissues, or developmental stages to an environmental hormone could be predicted with improved
accuracy. Also, it would be helpful to
model common steps in hormone action
such as ligand-receptor interactions
with responsive genes. Additionally, chemicals that share common pharmacologic
properties may share a common response
model. The work group cautions, however,
that endocrine disruption may occur
through mechanisms other than binding to
cellular receptors (i.e., inhibition of
enzymes of steroid hormone metabolism).
The existence of multiple mechanisms both
complicates evaluation of dose-response
relationships and offers opportunities to
better predict low-dose effects for different
kinds of mechanisms of endocrine disruption. In addition to studies of known receptors, there may be unknown receptors,
Are there unifying dose-response concepts including orphan receptors, on which new
for endocrine disruptors (i.e., threshold, research is needed.
linear, sublinear)?
There was considerable discussion of
The work group unanimously felt that a knowledge gaps in mechanisms of horcommon dose response for all effects and mone action, as these gaps create uncerfor all endocrine disruption should not be tainty in the evaluation of dose-response
from results from studies such as those on
cancer or reproduction. The work group felt
that such inferences of endocrine disruption
should lead to experimentation (toxicity,
mechanistic, epidemiological, field studies)
designed to characterize endocrine activity.
General recommendations for experimental studies. The work group recommended
an aggressive program of improving experimental design that should emphasize
the following:
a) Doses should span a wide range,
including environmentally relevant doses
for human, wildlife, and ecosystem exposures. A sufficient number of doses should
be used to characterize dose-response relationships for each relevant end point.
b) Studies should quantify and evaluate
multiple end points. End points should be
mechanistic and biological and should be
based on existing knowledge about the
structural properties and effects of the
chemical being studied.
c) End points should be quantified and
linked in the same animal or ecosystem, to
the extent possible, as well as across species
and ecosystems to facilitate the development of biologically based models for
estimating dose-response relationships.
d) The use of expanded protocols
should be selective and based on resources,
mechanistic knowledge, and risk assessment needs.
General recommendations for human
studies. The work group felt that there
are opportunities to use existing human
data and to conduct new research to
improve risk assessments for endocrine
disruptors. Specifically, the work group
recommends that
a) Existing records on occupational
and medical exposures to putative and
known endocrine disruptors should be
scrutinized for associations with altered
incidences of adverse health effects.
b) It would be helpful if consensus could
be reached on the most useful questions to
be included during medical examinations.
c) Biomarker studies need to address
comparative responses between experimental systems and humans.
d) Heterogeneity in dose response,
based on genetics, age, gender, and nutrition, needs to be characterized.
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relationships for endocrine disruptors.
Although a great deal is known about the
initial steps in hormone action such as
binding to receptors and transcriptional
activation of responsive genes, very little is
known about how those changes in gene
expression lead to biological effects such as
cell proliferation. This lessens the credibility
of biologically based models for predicting
dose-response relationships for endocrine
disruptors. However, several work group
members felt that such models still represent an improvement over the default
approaches currently used in risk assessments. For example, it may be possible to
compare potencies of chemicals apparently
acting through common mechanisms (i.e.,
binding to a specific receptor) and to better
predict targets or potentially sensitive cells
or tissues. It is also important to distinguish steps in the mechanism that can alter
the slope of the dose-response curve,
potency, or target organ specificity.
The role of interactions between
endogenous and exogenous hormones was
discussed. This led to the recommendation
that baseline data on endogenous hormones, including cyclicity and differences
in tissue concentrations, are needed not
only to improve the ability to predict the
environmental or health consequences of
endocrine disruptors but also as input into
mathematical models of development and
endocrine system function.
Finally, issues related to the doseresponse assessment of mixtures were
addressed. Considerable debate exists
regarding about dose-response relationships for single compounds even when a
reasonable amount of toxicologic data is
available. Yet humans and ecosystems are
exposed to a vast array of chemicals that
may interact by potentiation, synergism,
inhibition, and antagonism of toxic effects.
Although progress will be slow in risk
assessment of mixtures, the following
recommendations were developed:
a) Include environmentally relevant
doses and ratios of chemicals in ecological,
wildlife, and experimental animal studies
b) Use the knowledge of mechanisms
and appropriate biomarkers (sensitive and
specific) to dissect major contributors to
toxicity
c) Determine the pharmacokinetics of
toxic chemicals, within mixtures, and the
dose at target tissue
d) Improve TEF estimates for environmental agents that interact with specific
endogenous receptors (e.g., Ah and estrogen
receptor ligands) by systematically testing
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assumptions inherent to the TEQ approach. multidisciplinary research needed for the
These assumptions include the similarity of development of models for health and
mechanism and the role of persistence and environmental effects. Establishing crossaccumulation. The work group also felt that disciplinary programs for mathematical
TEF estimates would be improved by care- and simulation training for biologists and
ful selection of experimental systems used to biological training for statisticians and
determine relative potencies and the use of mathematicians would enhance the crediappropriate dose ranges, including low doses bility of biologically based models for
to separate direct from indirect effects on endocrine disruptors.
the endocrine system.
Exposure Assessment
Are there particular elements to be
considered in dose-response evaluation What chemicals in the environment are of
concern for endocrine disruption?
in wildlife species?
The work group felt that evaluation of The work group agreed that developing a
dose-response relationships to assess ecosys- comprehensive list of putative endocrine
tem and wildlife effects will be extremely disruptors would take longer than the time
difficult but would benefit by implementa- available at the workshop. Any list so constructed would not be entirely accurate or
tion of the following considerations:
a) Improved understanding of the fac- comprehensive at this time. Nonetheless,
tors, such as genetic diversity, that are from the viewpoint of exposure assesscritical to the maintenance of integrated ment, it was agreed that EDCs should be
ecosystems. It will be difficult to character- categorized as follows:
Use pattern-for example, herbicides,
ize dose-response relationships without
improved knowledge of normal fluctuations insecticides, fungicides, hormones, etc.
in ecosystem constituents.
Chemical structure or class-for
b) Laboratory and field studies need to example, dioxins, halogenated biphenyls,
be better coordinated. In addition, better alkyloxyphenols, etc.
Biological function and mechanism of
definition is needed of what constitutes
field validation of a laboratory finding as action-for example, estrogen mimic,
well as laboratory verification of an effect androgen inhibitor, etc.
observed in the field.
c) Guidelines need to be developed for What do we know about the status and
selection of sentinel species and evaluation trends ofputative EDC?
of dose-response relationships. Guidelines The initial discussion focused on what we
for dose-response assessment should be know and what we need to know about the
status and trends of putative EDCs.
general and not overly prescriptive.
Environmental and tissue levels of some
Is itfeasible to develop complete biologically EDCs, such as DDT and its analogs, and
based dose-response models for endocrine PCBs, have declined in some countries and
disruptors?
in most areas of the United States in
The work group encouraged the develop- response to regulation (171-178). Uncerment of biomathematical models for tainty still exists regarding future trends of
endocrine systems, recognizing that there these compounds, however, because of offwill not be a single model applicable to all shore inputs and releases from stored matehormones. However, the shared steps for rials. It also appears that for many EDCs,
some systems (e.g., hormone receptor bind- the environmental concentrations that
ing) could be modeled using the same set of declined from the mid-1970s through the
equations. These models should incorpo- early 1980s have now reached a plateau
rate data from humans, rodents, and the (179,180). This is a cause for concern. For
ecological species. Development of these most other EDCs, particularly new chemimodels must include time dependence of cals or chemicals that have not been rouhormonal action.
tinely monitored, the trends are unknown.
The information needs regarding status
Statistical and mathematical models for
toxic end points such as cancer, reproduc- and trends of EDCs are considerable. A
tion, or development should be helpful in better understanding is needed of the fate
identifying knowledge gaps that create and transport of new and existing chemiuncertainty in dose-response estimates and, cals, particularly among the different enviin this way, can focus available resources in ronmental compartments (water, sediment,
the most productive way. These efforts will biota). Key concerns have been raised about
require increased resources for fostering the air and water serving as transport media

and exposure routes for EDCs for both
humans and wildlife. The importance of
water use practices and how they impact
on exposure must be more thoroughly
investigated. Water use practices that contribute to EDC exposure, such as agriculture, sewage discharge, unfinished waters,
and unregulated drinking water sources,
require review. Any research on water use
must consider factors that affect flow and
dilution such as season, diversion, and
regulated release of impounded waters.
Exposure assessment, particularly as it
involves human health, must focus on vulnerable groups, both in terms of life stage
and lifestyle. Exposure assessment for the
critical development stages is a high
research priority. This includes pregnancy,
gestation, lactation, adolescence, and senescence. Vulnerability of different groups in
the population will be affected by lifestyle
factors such as subsistence hunting and
fishing and avid sportsmen who consume
fish and wildlife, or host factors such as
metabolic differences among polymorphic
groups, special dietary habits, and age (e.g.,
the types and rates of food consumption in
children). While the work group agreed
that diet would likely be the major exposure
route, an approach based on integrated
exposure assessment needs to be taken. All
routes should be examined (e.g., dermal,
inhalation, and ingestion). The work group
stressed the importance of a global perspective on exposure. EDCs that may have
restricted or no use in the United States are
still used in other countries and may become
sources of exposure through either imported
food or atmospheric transport and deposition. Further, the potential for human or
wildlife exposure to multiple chemicals that
may function as EDCs should be included
in any exposure assessment.
The most critical need on status and
trends is for the continuation and improvement of monitoring of the environment for
the presence and magnitude of contaminants. Existing programs that furnish
repeated measures of chemical contamination in the environment or in food provide
our only indication of whether exposure is
increasing or decreasing, and to what magnitude. Therefore, the work group strongly
recommended continuation of existing
programs such as the National Human
Health and Nutrition Examination Survey
(NHANES) (181); the National Human
Exposure Assessment Survey (NHEXAS)
(182); the Market Basket Analysis of the
U.S. Food and Drug Administration; the
Pesticide Data Program of the U.S.
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Department of Agriculture; the National
Contaminant Biomonitoring Program of the
National Bureau of Standards (173,183);
and the NOAA Status and Trends Program
(184). Existing international monitoring
efforts must be continued. For new programs or for improving existing programs,
the work group felt analytical expenses
could be reduced through specificity of
analysis. Where markers or bioassays are
able to replace chemical analysis, they
should be used, and analytes should be targeted to meet the specific monitoring need
of the designed program.
More research needs to be focused on
development and validation of monitoring
tools. Current results with caged organisms
have been successful because they provide
biologic relevance to the estimation of exposure. Despite the drawbacks inherent in
using caged organisms, such as stress associated with captivity and the absence of exposure during the sensitive reproductive and
developmental stages, the work group felt
this tool warranted further development.
Research also should continue on other
monitoring tools such as in situ samplers
that mimic biological tissue, or assays used
with field grab samples. As field tools to
measure exposure assessment become more
available, concurrent research in toxicity
identification evaluation (TIE) procedures
(185) must occur to enable verification of
causative agents.
What are the assumptions in estimating
exposure to endocrine disruptors?
Valid exposure assessment requires that certain assumptions be either accepted or
proven. The work group assumed that environmental concentrations did not equate to
exposure because of several factors. Activity
patterns such as migratory behavior, bioavailability of compounds, and lifecycle stage are
examples of factors that limit the use of environmental concentrations. Body burdens
may be much better indicators of exposure,
especially for persistent chemicals, but they
also may vary seasonally and with age (186).
However, research is needed to develop tissue-specific body burdens and determine
how they translate to specific dose. This will
require full understanding of the physiology
and toxicokinetics of the compound and its
host. Assessing bioavailability is complicated
by transplacental boundaries, interaction
with transport molecules, and matrix binding
(e.g., sediment particles, dissolved organic
carbon) and should be a focus of research.
Another critical assumption can be
made based on knowledge of the actions of
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EDCs; that is, a population of breeding
adults with apparently healthy offspring, or
young in the population does not necessarily indicate health. The ability of some
EDCs to evoke transgenerational effects
requires a more in-depth look at the health
of a population. Reproductive capacity and
normal reproductive functioning of the
offspring may be the most sensitive test of
population health. Research is needed to
develop preclinical indicators of transgenerational impacts so that they can be linked
to strategies that limit or eliminate exposure.
To what degree can body burdens in the
generalpopulations ofhumans and wildlife
be identified by exposure or hostfactors?
One of the research needs that was
identified and given the highest priority was
the further development and validation of
indicators of exposure to EDCs. Whether
these indicators are biomarkers or bioassays,
they must be sensitive and specific to both
persistent and nonpersistent compounds.
These indicators must be validated on a
species-by-species basis. Examples of some
measures that have been applied include
vitellogenin production in male fish
(158,187) and induction of cytochrome
P450 (188), although in both instances,
lack of response does not necessarily equate
to lack of exposure.
In addition to bioindicators, other
indices that may be termed population measures need to be applied to EDC exposure.
Sperm counts, sex ratios, and incidence of a
specific tumor or abnormality are examples
(74,189-191). If these prove to be indices
of effect, changes in these population measures could be used to identify populations
potentially exposed to EDCs. Exposure
indicators then could be used to quantify
the dose-response relationship. The work
group proposed a scenario in which indicators could be used in a tiered hierarchy that
would demonstrate evidence of exposure to
EDCs; clarification of the mechanism of
effect (e.g., estrogen mimic, androgen
inhibitor); and TIE methods to identify
responsible compounds. Given these needs,
indicators should be sensitive at ambient
levels of contamination and specific to
chemicals and end points that would enable
identification of mechanism of action.
Are there specific confounding factors or
temporalpatterns of eposure to be considered in the assessment ofpublk and wildlfe
health implications ofendocrine disruptors?
Estimating the exposure of humans and
wildlife to potential EDCs creates a unique

set of confounding factors. While this list is
certainly not comprehensive, the work group
identified the following significant factors:
a) Time lags between exposure and
effect: The transgenerational nature of
some EDC effects may be the single most
complicating factor. All of the potential
latent effects that may occur from shortterm exposures during critical developmental windows have not yet been identified.
b) Seasonality: Because of the sensitivity of reproductive stages to EDCs, seasonality will be extremely important to wildlife.
In addition, the association of EDCs with
the aquatic environment is complicated by
seasonal rainfall, storm runoff, and water
releases.
c) Species variability: Perhaps this is no
more important for EDC exposure than
with any other toxicant effect. However,
the work group particularly stressed that
more basic research is needed on general
endocrine physiology of target species.
d) Multiple chemical exposures: This,
too, is a confounding factor for any toxicant. It is especially identified here because
of the potential for joint toxic action and
the presence of naturally occurring
phytoestrogens.
A comprehensive list would identify a
number of general confounding factors such
as past exposure history, occupational exposures, nutritional status, trophic structure
and other relevant factors.
Summary of research needs for exposure

assessment.
A number of research needs were identified
in the previous section. The following list
was deemed to be of the highest priority:
a) Monitoring: Maintain and increase
monitoring efforts that help identify status
and trends of EDCs, including chemical
monitoring programs and population measures such as wildlife reproductive success,
sperm count studies, etc. These programs
are critical to the identification of populations at risk.
b) Biomarkers: Develop and validate
biological indices for use as screening tools.
More biomarkers, bioassays, and population measures are needed that are sensitive
at relevant environmental concentrations
and are mechanism specific.
c) Exposure hierarchies: Develop an
applied, integrative iterative hierarchy of
exposure indicators. Components should
range from screening level tests to much
more predictive indicators. This approach
should be designed to avoid false negatives
in initial tiers and progress in final tiers to
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The traditional risk assessment para- at multiple phylogenetic levels was deemed
digm can be used to adequately identify and the most important area in need of attencharacterize chemicals that cause adverse tion. It was repeatedly emphasized that the
Risk Characterizaton
effects by altering endocrine processes. developing embryo, fetus, and neonate
The National Academy of Sciences' Risk However, the assessment paradigm should should not be viewed as small adults and
Assessment paradigm was used as a tool to be tailored to permit consideration of such that the processes of development are
identify research needs. In this case, the factors as normal fluctuations of endoge- especially vulnerable to brief periods of
approach had limited success since the nous levels of hormones, impact of other endocrine disruption. However, for many
majority of the group members had limited agents (phytoestrogens), the existence of of the effects reported in both wildlife and
experience with the specific composition of critical windows of sensitivity, and the need humans that have been attributed to, or
a risk characterization. The work group, to understand the significance of subtle associated with, endocrine disruption, expohowever, did identify several major points effects at low doses. In other words, dose sure assessment has generally been inadeeffect may need to be expressed in several quate for quantitative risk assessment.
for which there was broad agreement.
Normal functioning of the endocrine contexts such as adult effects, adult dose Because of this, some participants felt it was
system encompasses a wide fluctuation of effect in a particular physiologic state (such difficult to critically evaluate and establish
hormone and other biological indices, as immediately postpartum or during lacta- the level of priority relative to other research
which reflect among other things, circadi- tion), or at a particular window of sensitivity topics. Still other participants reminded the
work group not to lose sight of the presence
an rhythm, season (temperature, light), for causing developmental toxicity.
Endocrine effects often occur subse- of naturally occurring endocrine disruptors
age, and gender. For example, concentration extremes of sex hormones occur at quent to receptor-ligand binding. A variety (e.g., phytoestrogens) as the effects of manspecified times for normal physiologic func- of agents may interact with a binding site made chemicals are studied.
Several general comments emanated
tions; such periods include sexual differ- acting as agonists, partial agonists, or antagentiation, puberty, reproductive cycles, par- onists. Since exposures may entail simulta- from the discussions. These include the
turition, lactation, and menopause. The neous interaction with various endogenous recognition that there was a great advanpresence and magnitude of certain hor- and exogenous substances, it is critical that tage in bringing together a multidisciplimones are critical to normal ontogenic receptor theory be used to develop or refine nary group of scientists representing both
development, including some neurobehav- quantitative models for estimating the the human health and ecological health
viewpoints to help identify common issues
ioral programming, in a broad range of effects of such exposures.
The limited utility, to date, of SAR to and that this interaction must be nurtured
biota that include insects and other invertebrates, amphibia, reptiles, fish, birds, predict biological effect for estrogenic as the research agenda unfolds. The work
and mammals. Studies in wildlife and in agents was noted. Perhaps a useful criterion group noted that some key similarities and
the laboratory have demonstrated that for screening EDCs for more robust study differences exist between endocrine disrupcertain chemicals may perturb specific is whether they can elicit (or inhibit in the tors and other chemicals that can cause
endocrine functions at specified periods case of antagonists) a transcriptional event. adverse biological effects. Two of the key
during the life span. The consequences of Such a criterion would only serve to screen differences are the presence of natural ligexposure during these windows of sensi- out agents; agents that met this sort of func- ands within the body that must interact at
tivity may manifest themselves at later tional definition would still need to be char- some level with the exogenous chemical;
periods of life. To better understand and acterized before determining if they have and that the concentrations of the natural
predict specific circumstances under actual toxicological potential. However, ligands within the body fluctuate during
which adverse effects may occur, it is such tests would still be limited in their the life cycle and must be maintained withessential that there be better identification abilities to detect the action of metabolites. in narrow limits at key times during develThe presumed receptor-based mecha- opment. This latter point indicates that
and characterization of these critical exposure windows. The homology of these sen- nisms, responsible for at least some adverse timing of exposure is a very significant facsitive periods across species is also impor- endocrine-modulated effects, present a tor in any assessment. Last, the mechanistic
tant for accurate risk prediction.
unique opportunity to establish a common basis of the interaction with biological sysTo understand the nature and degree to biologically relevant risk assessment process tems presages the induction of subtle
which an adverse effect reflects response to for all effects, i.e., developmental, immuno- effects at low doses that must be interpreted
a nonendogenous chemical with endocrine logic, neurological, and carcinogenic as to whether or not the effects are adverse.
properties or alters the type and magnitude effects. The group is not aware of a biolog- As the level of organization at which bioof endogenous hormones often requires ical basis for selecting different models to logic responses to endocrine disruptors are
consideration of a broad range of biologic quantitatively estimate cancer or non- observed decreases (e.g., from physiologic
interactions. For example, the role of agents cancer effects for chemicals that act by to cellular to molecular), the challenge to
describe the effects as adverse at the level of
from environmental sources such as phy- endocrine-mediated mechanisms.
the individual and the population increases.
toestrogens or estrogenic products from
In this regard, endocrine disruptors are not
fungi should be considered. It was recom- Summary Recommendations
mended that the current literature on phy- The majority of the participants at the unlike other types of chemicals for which
toestrogens be reviewed as a prerequisite workshop agreed that the endocrine dis- toxicologic information is amassed.
In general, it was felt that linking
for determining additional data needs in ruptor hypothesis was of sufficient concern
this area. A comprehensive bibliography to warrant a concerted research effort. In specific exposures to specific effects in the
for phytoestrogens is available on the particular, the study of potential effects on general environment would often be diffithe development of reproductive capability cult because of the complexities of exposure,
Internet (unpublished data).
more predictive indicators that are linked
to effects.
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the latency of the effects, and, at times, the
subtle nature of the outcomes. Therefore,
confirmation of the validity of the hypothesis will rely heavily on application of the
Hill criteria (192,193) for causality
(strength of the association, presence of a
dose-response relationship, specificity of
the association, consistency across studies,
biological plausibility, and coherence of the
evidence). Such considerations will have
significant impact on the types of research
activities necessary to adequately confirm

or refute the central hypothesis. A composite representation of the identified needs is
provided in Table 2. Ten broad categories
of research needs were identified: basic
research, biomarkers, database development, exposure determination, exposure
follow-up, hazard identification, mixtures,
multidisciplinary studies, risk assessment
models, and sentinel species. Within
each of these categories, the work groups
that identified each need are indicated.
The neurological, immunological and

carcinogenic work groups all noted the
complexity of identifying whether effects of
xenobiotics on those systems were the
result of primary or secondary aspects of
endocrine disruption. This concept is
developed in Figure 1, which portrays not
only the interaction between the endocrine
system and the target organs but also the
interactions among the target organs themselves. For these reasons, identifying agents
as direct or indirect endocrine disruptors is
problematic, and necessitates research to

Table 2. Composite research needs identified by the eight work groups.
Research need
Understanding the cellular and molecular mechanisms, including nonreceptor mechanisms, for EDCs
Sensitive, inexpensive, and widely available analytical tools
Animal and cellular models of endocrine-mediated tumors
Ontogeny of receptor-based systems and role in regulating development
Understanding of the mechanisms and biological significance of subtle low-dose effects
Identify and characterize critical windows of susceptibility across species
Characterize source of population heterogeneity in responsiveness (age, gender, nutrition, etc.)
Development of biomarkers of exposure and effects of EDCs
Biomarkers
Develop and validate biological indices as screening tools for exposure assessment
Development of biomarkers for latent effects
Information on normal population variation, regionnal, and seasonal effects
Database development
Critical review of short-term tests for EDCs
Prospective and retrospective reproductive health trends
Field data on hormone levels, body burdens, and gene expression markers
Systematic potency comparison of endogenous versus exogenous substances
Surveillance systems for cancer incidence and mortality in wildlife
Rapid and inexpensive exposure monitoring methods for use in wildlife populations
Exposure determination
EX
Increased monitoring efforts to identify status and trends of EDCs
Multidisciplinary teams to study exposed populations
Exposure follow-up
Autoimmune symptomology, hypersensitivity, and disease in EDC-exposed humans
Coordinated research on exposed humans, wildlife, and sentinel species
C, R, N, I
HD
Hazard identification
Target organ dosimetry for comparison with ligad-binding affinities
R, HD
Expanded development of QSAR models for hazard detection and ranking
RC
Identification of transcriptional events after ligand binding as QSAR input
R, HD
Development and validation of apical methods to detect EDCs
Perinatal and multigenerational exposure toxicity studies for cancer and noncancer effects
N, 1, HD
N
Research to address the additivity principle for mixtures
Mixtures
In vitro and in vivo studies of complex mixtures to evaluate validity of TEFs
R, HD, DR
Identification and testing of environmentally relevant mixtures
R, I,DR
C
Systematic evaluation of species-, cellular-, and age-dependent response to mixtures of EDCs
N
Systematic field and laboratory studies focused on critical uncertainties
Multidisciplinary studies
R, HD, DR
Laboratory-field hypothesis-based studies and improved information exchange
HD
Examination of correlation of effects between wildlife and mammalian models
Multidisciplinary studies on effects of endocrine disruption
N, I,DR
HD
Examination of multiple end points and multiple tests of ED action
R
Statistical models to predict risk from exposure and effects
Risk assessment models
DR
Improvements in study design (dose selection, end points, end point linkages)
EX
Development of applied integrative iterative hierarchy of exposure indicators
Evaluation of toxicity and mechanistic end points across species common steps and chemical classes)
C, DR
N
Toxicokinetics and toxicodynamic studies of environmentally relevant chemicals
Quantitative dose-response models based upon receptor theory and biochemical interactions
DR, RC
DR
Establishment of training programs in biomathematics for BBDR model construction
DR
Identification and monitoring of differentially susceptible sentinel species
Sentinel species
C, N, /,
C
Cancer studies in domestic animals and pets
"BBDR, biologically based dose-response model; C, carcinogenesis; R, reproductive toxicity; N, neurotoxicity; 1, immunotoxicity; HD, hazard detection; DR, dose response; EX,
exposure assessment; RC, risk characterization. Designations in bold and italics were among the highest priority needs identified by the respective work groups. In general,
carcinogenic and reproductive studies were considered to be higher priorities for biological effects research, while exposure assessment was a recognized deficiency in most
population studies.

Research area
Basic research
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carefully define dose-response relationships tem were considered to be high priority
across multiple end points, to delineate the for additional research because of the high
proximate mechanism of action, and to sensitivity and frequent irreversibility of
ascertain the complete organismal response effects after even brief exposures. More
to an environmental exposure. However, refined exposure assessments and research
in terms of protection of human or wildlife on the toxicology of mixtures were also
populations, it is less important to deter- considered to be of great importance.
mine whether effects are primary or Special emphasis was placed on the unique
secondary once they are observed in the challenges endocrine disruptors might
pose to the risk assessment paradigm.
general environment.
Workshop participants were in general Interestingly, understanding the basic
agreement that the highest priorities for mechanisms of endocrine disruption
biologic effect research lie in the areas of induced by various chemicals was seen as
development of reproductive capability an advantage in that this knowledge may
and carcinogenesis, as these end points result in a common, biologically based,
have had greater documentation of being risk assessment process for all effects (i.e.,
adversely affected by alterations in both cancer and noncancer).
endocrine function than have either the
At least three outcomes are expected
nervous or immune system. However, the from the workshop. The first of these is
incidence of effects on the nervous and the publication of this report in the
immune systems may be underestimated scientific literature so that it is readily
at this point because of incomplete available to both researchers and the pubcharacterization of the biologic effects of lic. Second, within the U.S. EPA, the
endocrine disruptors. In addition, it Office of Research and Development in
should be noted that many reproductive conjunction with input from the Program
effects, especially those involving a behav- Offices will be developing an augmented
ioral component, are mediated by effects research initiative beginning in Fiscal Year
on neuroendocrine function. In particular, 1996 to implement some of the recomidentification and characterization of mendations of the workshop. To assist in
effects on the developing reproductive sys- further focusing the research needs for

endocrine disruptors for research supported by the U.S. EPA, a workshop on ecological research needs was held in Duluth,
Minnesota, in June 1995 (151). Persons
seeking information from that effort
should contact Dr. Gary Ankley of the
MED/NHEERL/USEPA in Duluth.
Finally, an Endocrine Disruptor Research
Coordination Workshop has been formed
under the auspices of the National Science
and Technology Council that will a) develop a federal research strategy that addresses
the key scientific uncertainties for
endocrine disruptors, b) inventory related
ongoing federal research efforts, c) identify
research gaps between ongoing research
programs and needs identified in the strategic plan, and facilitate cooordination and
cooperation across the federal government
to address them, d) initiate outreach
efforts to engage public interest, private
sector, and international groups with interest in this issue, and e) promote educational activities such as symposia and workshops to disseminate endocrine disruptor
information across the scientific community. Persons wishing to find out more about
this effort should contact the senior author
of this report.
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